Processing 00000000.tx.1: Phosphorylation, Subcellular Localization, and Membrane Orientation of the Alzheimer's Disease-associated Presenilins* (Received for publication, May 30,1996, and in revised form, October 1,1996) Bart De Strooper , Monique Beullens , Bart Contreras , Lyne Levesque **, Katleen Craessaerts , Barbara Cordell , Dieder Moechars , Mathieu Bollen , Paul Fraser **, Peter St. 

Phrase: "Phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "Subcellular Localization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "Membrane Orientation of the Alzheimer's Disease-associated Presenilins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0029266:Orientation [Mental Process]
   744   C1704322:orientation [Spatial Concept]
   744   C1704972:Orientation [Spatial Concept]
   744   C3539923:Orientation [Intellectual Product]

Phrase: "*"

Phrase: "("

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "May 30,"

Phrase: "1996,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "October 1,"

Phrase: "1996"

Phrase: ")"

Phrase: "Bart De Strooper ,"

Phrase: "Monique Beullens ,"

Phrase: "Bart Contreras ,"

Phrase: "Lyne Levesque"

Phrase: "*"

Phrase: "*,"

Phrase: "Katleen Craessaerts ,"

Phrase: "Barbara Cordell ,"

Phrase: "Dieder Moechars ,"

Phrase: "Mathieu Bollen ,"

Phrase: "Paul Fraser"

Phrase: "*"

Phrase: "*,"

Phrase: "Peter St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]
Processing 00000000.tx.2: George-Hyslop ** and Fred Van Leuven From the Experimental Genetics Group and Molecular Oncology Group, Center for Human Genetics, and the Laboratory of Biochemistry, Katholieke Universiteit, 3000Leuven, Belgium, the **Center for Research in Neurodegenerative Diseases, Department of Medicine (Neurology) and Medical Biophysics, University of Toronto, Toronto, Ontario M5S 1A8, Canada, and Scios Inc., Sunnyvale,California94043 ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION FOOTNOTES Acknowledgments Note Added in Proof REFERENCES ABSTRACT Presenilins 1and 2are unglycosylated proteins with apparent molecular mass of 45and 50kDa, respectively, in transfected COS-1 and Chinese hamster ovary cells. 

Phrase: "George-Hyslop"

Phrase: "*"

Phrase: "*"

Phrase: "and"

Phrase: "Fred Van Leuven From the Experimental Genetics Group"

Phrase: "and"

Phrase: "Molecular Oncology Group,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1518578:Oncology Group [Professional or Occupational Group]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   734   C0596960:molecular oncology [Biomedical Occupation or Discipline]

Phrase: "Center for Human Genetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "the Laboratory of Biochemistry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "Katholieke Universiteit,"

Phrase: "3000Leuven,"

Phrase: "Belgium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "the **Center for Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0683939:center research [Manufactured Object,Organization]
   770   C0205099:Center [Spatial Concept]

Phrase: "in Neurodegenerative Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "Department of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "(Neurology"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: ")"

Phrase: "and"

Phrase: "Medical Biophysics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005553:Biophysics [Biomedical Occupation or Discipline]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Ontario M5S 1A8,"

Phrase: "Canada,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "and"

Phrase: "Scios Inc.,"

Phrase: "Sunnyvale,"

Phrase: "California94043 ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION FOOTNOTES Acknowledgments"

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Added in Proof"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0556981:% proof [Quantitative Concept]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ABSTRACT Presenilins 1and 2are unglycosylated proteins with apparent molecular mass of 45and 50kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively,"

Phrase: "in transfected COS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0376702:COS-1 [Cell]
   827   C0454802:Cos [Geographic Area]

Phrase: "and"

Phrase: "Chinese hamster ovary cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.3: They colocalize with proteins from the endoplasmic reticulum and the Golgi apparatus in transfected and untransfected cells. 

Phrase: "They"

Phrase: "colocalize with proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "the Golgi apparatus in transfected"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   760   C0243111:apparatus [Manufactured Object]
   760   C1947951:Apparatus [Anatomical Structure]

Phrase: "and"

Phrase: "untransfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.4: In COS-1 cells low amounts of intact endogeneous presenilin 1migrating at 45kDa are detected together with relative larger amounts of presenilin 1fragments migrating between 18and 30kDa. 

Phrase: "In COS-1 cells low amounts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1265611:amounts [Quantitative Concept]
   717   C1257857:COS-1 Cells [Cell]

Phrase: "of intact endogeneous presenilin 1migrating"

Phrase: "at 45kDa"

Phrase: "are"

Phrase: "detected together with relative larger amounts of presenilin 1fragments"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C0442726:Detected [Finding]
   742   C0443228:larger [Quantitative Concept]
   742   C0549177:Larger [Quantitative Concept]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C1265611:amounts [Quantitative Concept]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1547039:*Relative [Quantitative Concept]
   742   C1704243:Larger [Quantitative Concept]
   742   C1883357:Together [Qualitative Concept]

Phrase: "migrating between 18and 30kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0232902:migrating [Functional Concept]
Processing 00000000.tx.5: The presenilins have a strong tendency to form aggregates (mass of 100-250 kDa) in SDS-polyacrylamide gel electrophoresis, which can be partially resolved when denatured by SDS at 37C instead of 95C. 

Phrase: "The presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "a strong tendency to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "(mass of 100-250 kDa)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]

Phrase: "in SDS-polyacrylamide gel electrophoresis,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   923   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "partially"

Phrase: "resolved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]

Phrase: "when"

Phrase: "denatured by SDS"

Phrase: "at 37C"

Phrase: "instead of 95C."
Processing 00000000.tx.6: Sulfation, glycosaminoglycan modification, or acylation of the presenilins was not observed, but both proteins are posttranslationally phosphorylated on serine residues. 

Phrase: "Sulfation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597538:Sulfation [Phenomenon or Process]

Phrase: "glycosaminoglycan modification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "or"

Phrase: "acylation of the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001383:Acylation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "but"

Phrase: "both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "posttranslationally"

Phrase: "phosphorylated on serine residues."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.7: The mutations Ala-246 Glu or Cys-410 Tyr that cause Alzheimer's disease do not interfere with the biosynthesis or phosphorylation of presenilin 1.

Phrase: "The mutations Ala-246 Glu"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0051079:Ala-Glu [Amino Acid, Peptide, or Protein]
   812   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "Cys-410 Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1421250:TYR [Gene or Genome]

Phrase: "that cause Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with the biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005572:biosynthesis [Functional Concept]
   770   C0220781:Biosynthesis [Biologic Function]
   770   C0521102:Interfere [Qualitative Concept]

Phrase: "or"

Phrase: "phosphorylation of presenilin 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.8: Finally, using low concentrations of digitonin to selectively permeabilize the cell membrane but not the endoplasmic reticulum membrane, it is demonstrated that the two major hydrophilic domains of presenilin 1are oriented to the cytoplasm. 

Phrase: "Finally,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "low concentrations of digitonin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "to selectively"

Phrase: "permeabilize"

Phrase: "the cell membrane"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0007603:Cell Membrane [Cell Component]
  1000   C3161472:Cell Membrane [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1706182:Membrane [Manufactured Object]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the endoplasmic reticulum membrane,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0230770:endoplasmic reticulum membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "it"

Phrase: "is"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the two major hydrophilic domains of presenilin 1are"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "oriented to the cytoplasm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C1704322:Oriented [Spatial Concept]
Processing 00000000.tx.9: The current investigation documents the posttranslational modifications and subcellular localization of the presenilins and indicates that postulated interactions with amyloid precursor protein metabolism should occur in the early compartments of the biosynthetic pathway. 

Phrase: "The current investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "documents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301746:Documents [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]
  1000   C1548385:documents [Intellectual Product]

Phrase: "the posttranslational modifications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033666:Post-Translational Modifications [Molecular Function]
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "subcellular localization of the presenilins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "indicates"

Phrase: "that postulated interactions with amyloid precursor protein metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interactions protein [Molecular Function]
   711   C1704675:Interaction [Functional Concept]

Phrase: "should"

Phrase: "occur in the early compartments of the biosynthetic pathway."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C1721101:Pathway, Biosynthetic [Molecular Function]
   742   C0220781:Biosynthetic [Biologic Function]
   742   C1185625:Compartments [Body Space or Junction]
   742   C1279919:Early [Temporal Concept]
   742   C1382196:Compartments [Natural Phenomenon or Process]
   742   C1704259:Pathway [Molecular Function]
   742   C1705987:Pathway [Conceptual Entity]
   742   C1709305:Occur [Activity]
   742   C2745955:OCCUR [Temporal Concept]
   708 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.10: INTRODUCTION Alzheimer's disease is a major health problem. 

Phrase: "INTRODUCTION Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a major health problem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033213:Problem [Finding]
Processing 00000000.tx.11: Patients suffer from a progressive dementia caused by massive neuronal loss in cortical and hippocampal areas of the brain (1-6). 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "suffer from a progressive dementia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0743039:Dementia, progressive [Disease or Syndrome]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0205329:Progressive [Functional Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C0683278:suffer [Mental or Behavioral Dysfunction]

Phrase: "caused by massive neuronal loss"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1850496:Neuronal loss [Finding]
   770 E C0598940:neuron loss [Finding]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C0522501:Massive [Qualitative Concept]
   760   C1517945:Loss [Quantitative Concept]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "in cortical"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0001613:Cortical [Body Part, Organ, or Organ Component]
  1000   C0007776:Cortical [Body Part, Organ, or Organ Component]
  1000   C0022655:Cortical [Body Part, Organ, or Organ Component]
   944 E C0234875:bark [Organism Attribute]
   944 E C2700441:Bark [Plant]
   916 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   916 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "hippocampal areas of the brain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "(1-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Neuropathological signs of the disease are tangles and amyloid deposits in the brain parenchyma, and amyloid deposits in the brain vasculature. 

Phrase: "Neuropathological signs of the disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0220912:signs [Functional Concept]
   760   C0220913:signs [Manufactured Object]
   760   C0311392:SIGNS [Finding]
   726 E C1547188:Sign [Idea or Concept]

Phrase: "are"

Phrase: "tangles"

Phrase: "and"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits in the brain parenchyma,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0333562:Deposit [Functional Concept]
   760   C0933845:Parenchyma [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits in the brain vasculature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005839:vasculature [Body Part, Organ, or Organ Component]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0333562:Deposit [Functional Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.13: The cause of the sporadic form of the disease is still unknown, although an increased risk is associated with the presence of apolipoprotein allele E4 (6, 7). 

Phrase: "The cause of the sporadic form of the disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1314792:disease cause [Functional Concept]
   742   C0015127:cause [Functional Concept]
   742   C1524003:Cause [Conceptual Entity]

Phrase: "is"

Phrase: "still unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]

Phrase: "although"

Phrase: "an increased risk"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   861   C0035647:Risk [Qualitative Concept]
   861   C0205217:Increased [Quantitative Concept]
   861   C0442805:Increased [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0439661:Acquired [Temporal Concept]
   768 E C0442808:Increasing [Functional Concept]
   768 E C1301820:Obtain [Functional Concept]
   768 E C1706701:Acquire [Activity]
   768 E C3245488:acquired [Intellectual Product]

Phrase: "is"

Phrase: "associated with the presence of apolipoprotein allele E4"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   789   C3642141:Apolipoprotein E4 Allele [Gene or Genome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C0052201:Apolipoprotein E4 [Amino Acid, Peptide, or Protein]
   744   C0002085:Allele [Gene or Genome]
   744   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.14: On the other hand, familial early onset Alzheimer's disease is caused by point mutations in the amyloid precursor protein gene on chromosome 21(8), in the presenilin 2(PS2)1 gene on chromosome 1(9-11), or, most frequently, in the presenilin 1(PS1) gene on chromosome 14(12-15). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "familial early onset Alzheimer's disease"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   937   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   911   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   897   C0277558:Familial disease [Disease or Syndrome]
   875   C0679245:early disease [Temporal Concept]
   862 E C0344339:family disease [Finding]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   840   C1833334:Early-onset [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0332162:Onset [Qualitative Concept]
   804   C1279919:Early [Temporal Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "caused by point mutations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   770   C0026882:Mutations [Genetic Function]
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "on chromosome 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008664:Chromosome 21 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "in the presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS2"

Phrase: ")"

Phrase: "1 gene on chromosome 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Gene [Gene or Genome]

Phrase: "(9-11"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: ","

Phrase: "most frequently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332183:Frequently [Temporal Concept]

Phrase: "in the presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: "gene on chromosome 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Gene [Gene or Genome]

Phrase: "(12-15"

Phrase: ")."
Processing 00000000.tx.15: Amyloid precursor protein (APP) is a type I integral membrane protein and is the precursor of the amyloid peptide, the main component of the senile plaques (1-3). 

Phrase: "Amyloid precursor protein (APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "a type I integral membrane protein"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C0021699:Integral Membrane Protein [Amino Acid, Peptide, or Protein]
   875   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0443238:Integral [Quantitative Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "the precursor of the amyloid peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709634:Precursor [Idea or Concept]

Phrase: "the main component of the senile plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Point mutations in exons 16and 17of the APP gene cause alterations in the metabolism of APP. 

Phrase: "Point mutations in exons 16and 17of"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   753   C0026882:Mutations [Genetic Function]
   753   C1552961:Point [Quantitative Concept]
   753   C2347617:point [Quantitative Concept]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the APP gene cause alterations in the metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0596611:Gene Alteration [Genetic Function]
   706   C1515926:Alteration [Idea or Concept]

Phrase: "of APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.17: This results in an increased production of intracellular A4 amyloid peptide containing carboxyl-terminal APP fragments and in an increased secretion of the potentially neurotoxic A4 peptide (1-3, 16). 

Phrase: "This results in an increased production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "of intracellular A4 amyloid peptide containing carboxyl-terminal APP fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   860   C0030935:Peptide Fragments [Amino Acid, Peptide, or Protein]
   788   C0332255:fragments [Functional Concept]
   788   C0486805:Fragments [Body Substance]
   784   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   755 E C1708096:Fragment [Qualitative Concept]

Phrase: "and in an increased secretion of the potentially neurotoxic A4 peptide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   754   C1819802:peptide secretion [Cell Function]
   738   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   738   C0036536:secretion [Biologic Function]
   738   C0036537:Secretion [Body Substance]
   738   C0205217:Increased [Quantitative Concept]
   738   C0442805:Increased [Functional Concept]
   738   C1515981:And [Idea or Concept]

Phrase: "(1-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.18: 63% of the amino acid residues in the sequences of the two presenilins are conserved, which strongly suggests that both proteins are involved in similar functions and have a similar pathogenic role in Alzheimer's disease. 

Phrase: "63% of the amino acid residues"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in the sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "of the two presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "conserved"

Phrase: ","

Phrase: "which strongly"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "involved in similar functions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0542341:Functions [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C2348205:Similar [Qualitative Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "have"

Phrase: "a similar pathogenic role in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.19: Based on computer algorithms, seven membrane spanning domains have been defined (9-15), although the possibility of nine transmembrane domains cannot be ruled out at this moment (17). 

Phrase: "Based on computer algorithms,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0002045:Algorithms [Intellectual Product]
   770   C0009622:Computer [Manufactured Object]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1553907:algorithm [Laboratory Procedure]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "seven membrane spanning domains"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   812   C0025255:Membrane [Tissue]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   779   C1711300:Span [Conceptual Entity]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C2700613:Span [Quantitative Concept]
   779   C3541951:Domain [Intellectual Product]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "(9-15"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the possibility of nine transmembrane domains"

Phrase: "cannot"

Phrase: "be"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out at this moment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.20: The amino-terminal domain and the acidic loop domain, located between transmembrane domains six and seven, are hydrophilic and can be alternatively spliced (9, 13). 

Phrase: "The amino-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the acidic loop domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "located between transmembrane domains six"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   773   C1519623:Transmembrane Domain [Amino Acid Sequence]
   760   C0205452:Six [Quantitative Concept]
   760   C1167322:transmembrane [Cell Component]
   760   C2752508:transmembrane [Cell Component]
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "seven,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "are"

Phrase: "hydrophilic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475370:Hydrophilic [Qualitative Concept]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "alternatively"

Phrase: "spliced"

Phrase: "(9,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.21: The mutations that cause familial Alzheimer's disease are found all over the protein, but the hydrophilic loop constitutes a "hot spot" with nine different mutations described to date (5, 15). 

Phrase: "The mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "familial Alzheimer's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "are"

Phrase: "found all over the protein,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "but"

Phrase: "the hydrophilic loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "constitutes"

Phrase: "a ""hot spot"""
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0263214:hot spot [Disease or Syndrome]
   901   C1521990:Hot Spot [Spatial Concept]
   901   C2947985:Hot Spot [Pharmacologic Substance]
   901   C2986491:Hotspot [Nucleotide Sequence]
   827   C0329155:Spot [Fish]
   827   C0444519:Hot [Qualitative Concept]
   827   C1427618:SPOT [Gene or Genome]
   827   C1705203:Spot [Conceptual Entity]
   827   C2350229:Hot [Natural Phenomenon or Process]

Phrase: "with nine different mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "described to date"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011008:Date [Temporal Concept]
   790   C1552738:described [Idea or Concept]
   790   C2348077:Date [Food]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.22: The biological function of the presenilins remains essentially unknown, but, interestingly, the 103carboxyl-terminal amino acid residues of PS2 can inhibit apoptosis in a "deathtrap" assay (18). 

Phrase: "The biological function of the presenilins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0031845:Biological function, NOS [Physiologic Function]
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0031843:function [Physiologic Function]
   753   C0205460:biological [Qualitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "remains"

Phrase: "essentially unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: ","

Phrase: "interestingly,"

Phrase: "the 103carboxyl-terminal amino acid residues of PS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis in a ""deathtrap"" assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.23: Based on the homology with Caenorhabditis elegans proteins, roles in intracellular protein sorting and/or intercellular signal transmission have been proposed as well (19, 20). 

Phrase: "Based on the homology"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C1334043:Homology [Gene or Genome]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C2697616:Homology [Qualitative Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "with Caenorhabditis elegans proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0949990:Caenorhabditis elegans Proteins [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0162610:Caenorhabditis elegans [Eukaryote]

Phrase: "roles in intracellular protein sorting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "and/or"

Phrase: "intercellular signal transmission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "have"

Phrase: "been"

Phrase: "proposed as well"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205170:Well [Qualitative Concept]
   790   C1441414:PROPOSED [Idea or Concept]
   790   C1553874:Proposed [Qualitative Concept]
   790   C1578820:Proposed [Idea or Concept]
   790   C3146287:Well [Manufactured Object]

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.24: A hypothetical final common pathway in the pathogenesis of the genetic and sporadic forms of Alzheimer's disease has been postulated, based on the invariable occurrence of the amyloid deposits, the neurofibrillar tangles and the neurodegeneration in all affected brains. 

Phrase: "A hypothetical final common pathway in the pathogenesis of the genetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1704259:Pathway [Molecular Function]
   738   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "sporadic forms of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: ","

Phrase: "based on the invariable occurrence of the amyloid deposits,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   764   C2936349:Amyloid Deposits [Acquired Abnormality]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0243132:occurrence [Functional Concept]
   742   C0333562:Deposits [Functional Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1527178:Based [Functional Concept]
   742   C1554210:occurrence [Idea or Concept]
   742   C1705938:Based [Idea or Concept]
   742   C2745955:Occurrence [Temporal Concept]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the neurofibrillar tangles"

Phrase: "and"

Phrase: "the neurodegeneration in all affected brains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.25: The central question is thus how mutations in the presenilin genes can cause this typical neuropathology. 

Phrase: "The central question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522634:Question [Intellectual Product]

Phrase: "is"

Phrase: "thus how mutations in the presenilin genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "this typical neuropathology."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   861   C1540677:neuropathology [Pathologic Function]
   861   C1555824:Neuropathology [Intellectual Product]
Processing 00000000.tx.26: Studies indicating an increased production of more amyloidogenic A4-(1-42) peptide in fibroblasts obtained from patients with presenilin mutations would support the amyloid hypothesis that postulates abnormal A4 amyloid peptide production and plaque formation as the pivotal event in the pathogenesis of the disease (2, 21). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "indicating"

Phrase: "an increased production of more amyloidogenic A4-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "peptide in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "obtained from patients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with presenilin mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "would"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the amyloid hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "postulates"

Phrase: "abnormal A4 amyloid peptide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "plaque formation as the pivotal event"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.27: However, the observed increases in A4-(1-42) peptide production were relatively small, and the suggested relationship between presenilin mutations and APP metabolism should be further corroborated by experiments showing directly the effect of presenilin mutations on APP processing in transfected cells or in brains of transgenic animals. 

Phrase: "However,"

Phrase: "the observed increases in A4-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "peptide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "were"

Phrase: "relatively small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]

Phrase: "and"

Phrase: "the suggested relationship between presenilin mutations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "APP metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1327340:amyloid precursor protein metabolism [Molecular Function]
   861   C0597299:Protein Metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "should"

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "corroborated by experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0681814:Experiments [Research Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "the effect of presenilin mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or in brains of transgenic animals."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0003069:Animals, Transgenic [Animal]
           Transgenic
   753   C0003062:Animals [Animal]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.28: Moreover, other aspects of APP metabolism such as the production of carboxyl-terminal APP fragments (16) should be investigated in greater detail. 

Phrase: "Moreover,"

Phrase: "other aspects of APP metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]

Phrase: "such as the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of carboxyl-terminal APP fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   810   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "should"

Phrase: "be"

Phrase: "investigated in greater detail."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0443228:greater [Quantitative Concept]
   770   C1292732:investigated [Functional Concept]
   770   C1522508:Detail [Qualitative Concept]
   770   C1561567:detail [Functional Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.29: The possibility that presenilins interact with the cytoskeleton or exert their effect via apoptotic pathways should not be disregarded at this time (18). 

Phrase: "The possibility"

Phrase: "that presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "interact with the cytoskeleton"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010853:Cytoskeleton [Cell Component]
   770   C1748451:Cytoskeleton [Cell Component]

Phrase: "or"

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "their effect via apoptotic pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "disregarded at this time"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.30: In addition to addressing these questions, basic information is needed on the subcellular localization, the posttranslational modifications, and the membrane orientation of the presenilins. 

Phrase: "In addition to addressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "these questions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522634:Question [Intellectual Product]

Phrase: "basic information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "needed on the subcellular localization,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0027552:Needed [Qualitative Concept]
   760   C0475264:Localisation [Functional Concept]
   760   C0686904:needed [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "the posttranslational modifications,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033666:Post-Translational Modifications [Molecular Function]
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "the membrane orientation of the presenilins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0029266:Orientation [Mental Process]
   753   C1704322:orientation [Spatial Concept]
   753   C1704972:Orientation [Spatial Concept]
   753   C3539923:Orientation [Intellectual Product]
Processing 00000000.tx.31: We used COS-1 cells and CHO cells to express PS1 and PS2, as well as Myc-tagged PS1 and PS1-containing mutations that cause familial Alzheimer's disease. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "CHO cells to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2,"

Phrase: "as well as"

Phrase: "Myc-tagged PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS1-containing mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "familial Alzheimer's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.32: The biosynthesis of transfected and untransfected presenilins was studied using immunoblotting or metabolical labeling and immunoprecipitation assays. 

Phrase: "The biosynthesis of transfected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005572:biosynthesis [Functional Concept]
   770   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "untransfected presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "or"

Phrase: "metabolical labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "immunoprecipitation assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.33: We demonstrate that transfected presenilins are phosphorylated on serine residues. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "that transfected presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "phosphorylated on serine residues."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.34: Using immunofluorescence microscopy, we document the association of presenilin 1with the early compartments of the biosynthetic pathway and demonstrate the cytoplasmic orientation of the two major hydrophilic domains. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunofluorescence microscopy,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "we"

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "the association of presenilin 1with"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "the early compartments of the biosynthetic pathway"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C1185625:Compartments [Body Space or Junction]
   748   C1382196:Compartments [Natural Phenomenon or Process]
   714 E C2986730:Compartment [Spatial Concept]

Phrase: "and"

Phrase: "demonstrate"

Phrase: "the cytoplasmic orientation of the two major hydrophilic domains."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0029266:Orientation [Mental Process]
   742   C1704322:orientation [Spatial Concept]
   742   C1704972:Orientation [Spatial Concept]
   742   C3539923:Orientation [Intellectual Product]
Processing 00000000.tx.35: MATERIALS AND METHODS Constructs The cDNA coding for mouse PS1 and human PS1, PS2, and PS1 containing Ala-246 Glu (FAD1) or Cys-410 Tyr (NIH2) mutations have been described (9, 12). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "Constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "The cDNA coding for mouse PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0009219:Coding [Occupational Activity]

Phrase: "and"

Phrase: "human PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "PS2,"

Phrase: "and"

Phrase: "PS1 containing Ala-246 Glu (FAD1"

Phrase: ")"

Phrase: "or"

Phrase: "Cys-410 Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1421250:TYR [Gene or Genome]

Phrase: "(NIH2"

Phrase: ")"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(9,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.36: A Myc-tagged PS1 fragment was generated by PCR using primers 5-CGGGATCCATTATGACAGAGTTACCTGCACCG-3 and 5-GATCACATGCTTGGCGCCATAT-3 (the sequence coding for the Myc tag is underlined). 

Phrase: "A Myc-tagged PS1 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "generated by PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 5-CGGGATCCATTATGACAGAGTTACCTGCACCG-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5-GATCACATGCTTGGCGCCATAT-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "("

Phrase: "the sequence coding for the Myc tag"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0079941:Coding Sequence [Gene or Genome]
   748   C0009219:Coding [Occupational Activity]

Phrase: "is"

Phrase: "underlined"

Phrase: ")."
Processing 00000000.tx.37: This fragment was used to replace the NarI/BamHI restriction fragment of PS1 in pSG5. 

Phrase: "This fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "the NarI/BamHI restriction fragment of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332255:fragment [Functional Concept]
   748   C0443288:Restriction [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "in pSG5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418997:PSG5 [Gene or Genome]
Processing 00000000.tx.38: The resulting cDNA codes for PS1 with the Myc tag (EQKLISEEDL) immediately after the initiator methionine, as confirmed by cDNA sequencing. 

Phrase: "The resulting cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "codes for PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0009219:code [Occupational Activity]
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0805701:Code [Intellectual Product]
   790   C0919279:codes [Classification]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "with the Myc tag (EQKLISEEDL"

Phrase: ")"

Phrase: "immediately after the initiator methionine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205548:Immediately [Temporal Concept]
   760   C1444748:Initiator [Qualitative Concept]

Phrase: "as"

Phrase: "confirmed by cDNA sequencing."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.39: Plasmids containing the cDNA for furin (22, 23) or reticulon/NSP (24, 25) were kindly provided by Dr. 

Phrase: "Plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the cDNA for furin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "reticulon/NSP (24,"

Phrase: "25"

Phrase: ")"

Phrase: "were"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.40: J.

Phrase: "J."
Processing 00000000.tx.41: Creemers, Dr. 

Phrase: "Creemers,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.42: A.

Phrase: "A."
Processing 00000000.tx.43: Roebroek, and Dr. 

Phrase: "Roebroek,"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.44: W.Van De Ven (Center for Human Genetics, Leuven, Belgium). 

Phrase: "W.Van De Ven"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0011198:DE [Geographic Area]
   812   C0017480:DE [Geographic Area]
   812   C0042469:VEN [Geographic Area]
   812   C0557775:Van [Manufactured Object]
   812   C3541240:DE [Idea or Concept]

Phrase: "(Center for Human Genetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "Leuven,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")."
Processing 00000000.tx.45: Antibodies Polyclonal rabbit antisera B13, B14, and B15 were raised against peptide p45 (NDNRERQEHNDRRSLC), which is in the amino-terminal domain of PS1 (12). 

Phrase: "Antibodies Polyclonal rabbit antisera B13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417625:B13 [Gene or Genome]

Phrase: "B14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417627:B14 [Gene or Genome]

Phrase: "and"

Phrase: "B15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417636:B15 [Gene or Genome]

Phrase: "were"

Phrase: "raised against peptide p45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0442818:Raised [Quantitative Concept]

Phrase: "(NDNRERQEHNDRRSLC"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is in the amino-terminal domain of PS1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0205088:Terminal [Temporal Concept]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1418985:PS1 [Gene or Genome]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C2986918:PS1 [Gene or Genome]
   744   C3541951:Domain [Intellectual Product]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.46: Polyclonal rabbit sera B16 and B17 were raised against peptide p46 (EGDPEAQRRVSKNSKC) situated in the hydrophilic loop domain of PS1. 

Phrase: "Polyclonal rabbit sera B16"

Phrase: "and"

Phrase: "B17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414132:B17 [Gene or Genome]
  1000   C1417638:B17 [Gene or Genome]

Phrase: "were"

Phrase: "raised against peptide p46"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0442818:Raised [Quantitative Concept]
   770   C1833604:p46 [Gene or Genome]

Phrase: "(EGDPEAQRRVSKNSKC"

Phrase: ")"

Phrase: "situated in the hydrophilic loop domain of PS1."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0419518:Loop [Medical Device]
   744   C0445022:Loop [Spatial Concept]
   744   C0475370:Hydrophilic [Qualitative Concept]
   744   C1418985:PS1 [Gene or Genome]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C2986918:PS1 [Gene or Genome]
   744   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.47: Polyclonal rabbit antiserum 519 was raised against residues KDGQLIYTPFTEDTE(C). 

Phrase: "Polyclonal rabbit antiserum 519"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0034493:Rabbit [Mammal]

Phrase: "was"

Phrase: "raised against residues KDGQLIYTPFTEDTE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442818:Raised [Quantitative Concept]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.48: This antiserum reacts with a sequence in the second loop domain of PS1 and PS2. 

Phrase: "This antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "reacts with a sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "in the second loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2."
Processing 00000000.tx.49: The synthetic peptides p45 and p46 were manufactured by Eurogentec (Lige, Belgium), while peptide p519 was synthesized by solid-phase techniques and purified by reverse phase high pressure liquid chromatography in our laboratories.2 Rabbits were injected every 2weeks with 100,200,or 300g of peptide in complete Freund's adjuvant, coupled to keyhole limpet hemocyanin or bovine serum albumin (Pierce) and solubilized in PBS mixed with complete Freund's adjuvant. 

Phrase: "The synthetic peptides p45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "p46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1833604:p46 [Gene or Genome]

Phrase: "were"

Phrase: "manufactured by Eurogentec"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0870840:manufactured [Occupational Activity]

Phrase: "(Lige,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "peptide p519"

Phrase: "was"

Phrase: "synthesized by solid-phase techniques"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025664:techniques [Intellectual Product]
   760   C0205208:Solid [Qualitative Concept]
   760   C0205390:Phase [Temporal Concept]
   760   C0302909:Solid [Substance]
   760   C0449851:Techniques [Functional Concept]
   760   C1378566:Solid [Biomedical or Dental Material]
   760   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "purified by reverse phase high pressure liquid chromatography"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   833   C0008562:Chromatography, High Pressure Liquid [Laboratory Procedure]
   819   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   793   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   770   C0008565:Liquid Chromatography [Laboratory Procedure]
   767   C0449252:Pressure phase [Temporal Concept]
   767   C1305710:Liquid pressure [Natural Phenomenon or Process]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0033095:Pressure [Phenomenon or Process]
   744   C0205250:High [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0302908:Liquid [Substance]
   744   C0460139:Pressure [Finding]
   744   C1299351:High [Qualitative Concept]
   744   C1304698:Liquid [Finding]
   744   C1306345:Pressure [Functional Concept]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1555029:Reverse [Idea or Concept]
   744   C1561501:Liquid NOS [Substance]
   744   C1998793:Purified [Functional Concept]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "in our laboratories.2 Rabbits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0178727:laboratory rabbit [Mammal]
   827   C0034493:Rabbit [Mammal]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "every 2weeks with 100,"

Phrase: "200,"

Phrase: "or"

Phrase: "300g of peptide"

Phrase: "in complete Freund's adjuvant,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0016712:complete Freund's adjuvant [Immunologic Factor,Pharmacologic Substance]
           Complete adjuvant
           Freund's Adjuvant
   827   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   827   C0001552:Adjuvant [Chemical Viewed Functionally]
   827   C0205197:Complete [Qualitative Concept]
   827   C0725685:COMPLEAT [Food]
   827   C1522673:Adjuvant [Functional Concept]
   755 E C0439812:Completeness [Qualitative Concept]

Phrase: "coupled to keyhole limpet hemocyanin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   862   C0064332:keyhole-limpet haemocyanin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018999:Haemocyanin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0324030:Limpet [Eukaryote]
   760   C1948027:Coupled [Functional Concept]
   760   C2350000:Limpet [Food]
   726 E C0010222:couple [Family Group]

Phrase: "or"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "and"

Phrase: "solubilized in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "mixed with complete Freund's adjuvant."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   862   C0016712:complete Freund's adjuvant [Immunologic Factor,Pharmacologic Substance]
           Freund's Adjuvant
           Complete adjuvant
   760   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   760   C0001552:Adjuvant [Chemical Viewed Functionally]
   760   C0205197:Complete [Qualitative Concept]
   760   C0205430:Mixed [Functional Concept]
   760   C0725685:COMPLEAT [Food]
   760   C1522673:Adjuvant [Functional Concept]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.50: Monoclonal antibody (mAb) PS1-3, reacting with the peptide RRVSKNSKYNAESTERESQDTVAEN in the hydrophilic loop domain of PS1 mAb 9E10 against the Myc tag (26), was kindly provided by Dr. 

Phrase: "Monoclonal antibody (mAb) PS1-3,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0746619:monoclonal [Finding]
   812   C1418985:PS1 [Gene or Genome]
   812   C2986918:PS1 [Gene or Genome]

Phrase: "reacting with the peptide RRVSKNSKYNAESTERESQDTVAEN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "in the hydrophilic loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of PS1 mAb 9E10"

Phrase: "against the Myc tag (26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037293:Tag [Neoplastic Process]
   827   C0181496:Tag [Manufactured Object]
   827   C1710492:TAG [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.51: J.

Phrase: "J."
Processing 00000000.tx.52: Creemers. 

Phrase: "Creemers."
Processing 00000000.tx.53: mAbs MON160, 161and 162and MON148 and 152against NSP/reticulon and furin have been described (22-25). 

Phrase: "mAbs MON160,"

Phrase: "161and 162and MON148"

Phrase: "and"

Phrase: "152against NSP/reticulon"

Phrase: "and"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(22-25"

Phrase: ")."
Processing 00000000.tx.54: mAbs against the immunoglobulin-binding protein (BiP) and against the calcium pump Serca 2a (IID8) were purchased from, respectively, StressGen (Victoria, Canada) and Affinity BioReagents (Neshanic Station, NJ). 

Phrase: "mAbs against the immunoglobulin-binding protein (BiP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and against the calcium pump Serca 2a"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0001476:Calcium pump [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1749451:calcium pump [Molecular Function]
   748   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0006726:Calcium [Inorganic Chemical]
   748   C0182537:Pump [Medical Device]
   748   C1515981:And [Idea or Concept]
   748   C1706421:Pump [Manufactured Object]
   748   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(IID8"

Phrase: ")"

Phrase: "were"

Phrase: "purchased from,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0869011:purchased [Activity]

Phrase: "respectively,"

Phrase: "StressGen"

Phrase: "(Victoria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042645:Victoria [Geographic Area]
  1000   C0997115:Victoria [Plant]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "Affinity BioReagents"

Phrase: "(Neshanic Station,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883167:Station [Manufactured Object]
   789 E C0439835:Stationary [Qualitative Concept]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.55: Cell Culture, Metabolic Labeling, Cell Extraction, and Immunoprecipitation The fibroblast cell line (designation AG07657, Coriell Institute) from an unaffected individual of the FAD1 lineage was cultured in Dulbecco's modified Eagle's medium supplemented with 20% fetal bovine serum (Life Technologies, Inc.). 

Phrase: "Cell Culture,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "Metabolic Labeling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "Cell Extraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "The fibroblast cell line"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0682524:fibroblast cell line [Cell]
   901   C0007600:Cell Line [Cell]
   901   C0016030:fibroblast cell [Cell]
           Fibroblast
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(designation AG07657,"

Phrase: "Coriell Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "from an unaffected individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027361:Individual [Population Group]
   861   C0237401:Individual [Human]

Phrase: "of the FAD1 lineage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881379:Lineage [Conceptual Entity]

Phrase: "was"

Phrase: "cultured in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with 20% fetal bovine serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.56: COS1 cells were cultured as described previously in Dulbecco's modified Eagle's medium/Ham's F-12 with 10% fetal bovine serum (27). 

Phrase: "COS1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously in Dulbecco's modified Eagle's medium/Ham's F-12"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   742   C0009458:Medium [Intellectual Product]
   742   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   742   C0325564:Eagle [Bird]
   742   C0392747:Modified [Functional Concept]
   742   C0439133:(f) [Intellectual Product]
   742   C0439536:Medium [Quantitative Concept]
   742   C1551720:Eagle [Population Group]
   742   C1553038:[f] [Quantitative Concept]
   742   C1705217:Medium [Substance]
   742   C3244283:medium [Intellectual Product]

Phrase: "with 10% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.57: CHO cells stably transfected with APP770 were kindly provided by Dr. 

Phrase: "CHO cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with APP770"

Phrase: "were"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.58: B.

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.59: Greenberg (Cephalon, West Chester, PA) and cultured in high glucose Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 0.1 mM minimal essential medium (nonessential amino acids), 3% fetal calf serum, and 250nM methotrexate. 

Phrase: "Greenberg"

Phrase: "(Cephalon,"

Phrase: "West Chester,"

Phrase: "PA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "and"

Phrase: "cultured in high glucose Dulbecco's modified Eagle's medium"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   770   C0860803:high glucose [Finding]
   750   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   750   C0680299:high culture [Population Group]
   744   C0009458:Medium [Intellectual Product]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0205250:High [Qualitative Concept]
   744   C0325564:Eagle [Bird]
   744   C0392747:Modified [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1551720:Eagle [Population Group]
   744   C1705217:Medium [Substance]
   744   C2700149:HIGH [Intellectual Product]
   744   C3244283:medium [Intellectual Product]
   711   C0010453:Culture [Idea or Concept]
   711   C0220814:culture [Functional Concept]
   711   C0430400:Culture [Laboratory Procedure]
   711   C2242979:Culture [Laboratory Procedure]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "supplemented with 0.1 mM minimal essential medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C1418486:MM-1 [Gene or Genome]
   744   C0009458:Medium [Intellectual Product]
   744   C0205224:Essential [Qualitative Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C0547040:Minimal [Qualitative Concept]
   744   C1524031:MINIMAL [Qualitative Concept]
   744   C1705217:Medium [Substance]
   744   C2945599:Minimal [Qualitative Concept]
   744   C3244283:medium [Intellectual Product]
   711   C0242295:Supplement [Food]
   711   C1947943:Supplement [Intellectual Product]
   711   C2348609:Supplement [Functional Concept]

Phrase: "(nonessential amino acids"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "3% fetal calf serum,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "and"

Phrase: "250nM methotrexate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025677:Methotrexate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.60: COS cells were transfected using DEAE/dextran (27), while CHO cells were transfected using LipofectAMINE according to the instructions of the manufacturer (Life Technologies, Inc.). 

Phrase: "COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DEAE/dextran"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011051:DEAE-Dextran [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   861   C0046079:DEAE [Organic Chemical,Pharmacologic Substance]
   861   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LipofectAMINE according to the instructions of the manufacturer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.61: Metabolic labeling was done with 100Ci of [35S]methionine, 250Ci of [35S]sulfate, 60Ci of [3H]glucosamine, 500Ci of [3H]palmitic acid or [3H]myristic acid, or 500Ci of [32P]orthophosphate/ml of the appropriate culture medium. 

Phrase: "Metabolic labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "done with 100Ci of [35S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1272695:Done [Qualitative Concept]
   760   C2746065:Done [Temporal Concept]

Phrase: "]methionine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "250Ci of [35S"

Phrase: "]sulfate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038720:Sulfate [Inorganic Chemical]
  1000   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
  1000   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "60Ci of [3H]glucosamine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]
   812   C1442460:3H [Temporal Concept]

Phrase: "500Ci of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]palmitic acid or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442460:3H [Temporal Concept]

Phrase: "]myristic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027138:Myristic Acid [Biologically Active Substance,Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "500Ci of [32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553631:32p [Medical Device]

Phrase: "]orthophosphate/ml of the appropriate culture medium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.62: All radiolabeled precursors were from Amersham. 

Phrase: "All radiolabeled precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709634:Precursor [Idea or Concept]

Phrase: "were from Amersham."
Processing 00000000.tx.63: Cellular labeling was done for 4h unless otherwise specified, and cell extracts were made as described previously (27). 

Phrase: "Cellular labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "done for 4h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1272695:Done [Qualitative Concept]
   790   C1292426:4H [Temporal Concept]
   790   C2746065:Done [Temporal Concept]

Phrase: "unless"

Phrase: "otherwise"

Phrase: "specified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205369:Specified [Qualitative Concept]
   966 E C1521902:Specify [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.64: For analysis of phosphorylation, a postnuclear extract was prepared using 0.5% (v/v) Triton X-100 in Tris-buffered saline (TBS) containing proteinase inhibitors (100units/ml aprotinin, 1g/ml pepstatin) and tyrosine and serine/threonine phosphatase inhibitors (1mM sodium orthovanadate, 5mM EDTA, 5mM EGTA, 20mM NaF). 

Phrase: "For analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "a postnuclear extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "(v/v) Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "in Tris-buffered saline (TBS) containing proteinase inhibitors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   799   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   799   C0243077:inhibitors [Chemical Viewed Functionally]
   799   C1622131:proteinase [Molecular Function]
   799   C1947941:Proteinase [Enzyme]
   793   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   793   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C2673177:proteinase inhibitor [Molecular Function]
   766 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(100units/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1g/ml pepstatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "serine/threonine phosphatase inhibitors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   844   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]
   756   C0031686:Serine-Threonine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1mM sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0029366:Orthovanadate [Inorganic Chemical]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "5mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "5mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "20mM NaF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   861   C1366571:NAF [Gene or Genome]
   861   C1705592:NAF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.65: The nuclei were pelleted by centrifugation at 14,000rpm (15min) in a cooled Eppendorf centrifuge. 

Phrase: "The nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "pelleted by centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0441436:Pellet [Manufactured Object]
   756   C0993610:Pellet [Biomedical or Dental Material]
   756   C1998480:Pellet [Quantitative Concept]

Phrase: "at 14,"

Phrase: "000rpm"

Phrase: "(15min"

Phrase: ")"

Phrase: "in a cooled Eppendorf centrifuge."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0179834:centrifuge [Medical Device]
Processing 00000000.tx.66: Antisera were added to the cell extracts at a 1/250 dilution, and antibody-antigen complexes were collected by incubation with immobilized protein G (Pierce) overnight at 4C. 

Phrase: "Antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "added to the cell"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1524062:Added [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "extracts at a 1/250 dilution,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1948037:Dilution [Functional Concept]
   753   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "antibody-antigen complexes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]
   734   C0368675:antibody antigen [Immunologic Factor]

Phrase: "were"

Phrase: "collected by incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "with immobilized protein G"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0060916:protein g [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]
Processing 00000000.tx.67: The immunoprecipitates were washed using Tris-buffered saline containing 1% (v/v) Triton X-100, 1% (w/v) deoxycholate, and 0.1% (w/v) SDS (27). 

Phrase: "The immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(v/v) Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "deoxycholate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "0.1%"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "SDS (27"

Phrase: ")."
Processing 00000000.tx.68: For analysis of phosphorylation, phosphatase inhibitors as detailed above, were added to all buffers. 

Phrase: "For analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "phosphatase inhibitors as detailed above,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "added to all buffers."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.69: Phorbol myristic acid, phorbol dibutyric acid, forskolin, okadaic acid and staurosporin (all from Sigma) were added to the cell cultures during the last 30min of the metabolic labeling at the indicated final concentrations. 

Phrase: "Phorbol myristic acid,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0767601:phorbol myristic acid [Biologically Active Substance,Organic Chemical]
   901   C0027138:Myristic Acid [Biologically Active Substance,Lipid]
   827   C0001128:Acid [Chemical]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "phorbol dibutyric acid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "forskolin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "staurosporin"

Phrase: "("

Phrase: "all from Sigma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444868:All [Quantitative Concept]
   790   C1719918:Sigma [Intellectual Product]
   790   C3539085:All [Idea or Concept]

Phrase: ")"

Phrase: "were"

Phrase: "added to the cell cultures"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0007585:Cell Cultures [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0010453:Cultures [Idea or Concept]
   760   C1269647:Cell [Cell]
   760   C1524062:Added [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C1883712:Add [Functional Concept]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "during the last 30min"

Phrase: "of the metabolic labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "at the indicated final concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.70: For in vitro labeling assays, immunoprecipitated PS1 or PS2 bound on protein G beads were incubated with purified protein kinase A or C in Tris-buffered saline, in the presence of 0.1mM [-32P]ATP, 2mM Mg2+ during 60min at 30C. 

Phrase: "For in vitro labeling assays,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   906   C1515653:In Vitro Assay [Research Activity]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "immunoprecipitated PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "PS2"

Phrase: "bound on protein G beads"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0522527:Protein bound [Qualitative Concept]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332297:bound [Spatial Concept]
   760   C0439267:g% [Quantitative Concept]
   760   C0991566:Beads [Biomedical or Dental Material]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]
   726 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "incubated with purified protein kinase A"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1998793:Purified [Functional Concept]

Phrase: "or"

Phrase: "C in Tris-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0036082:Saline [Substance]
   804   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   804   C0814229:TRI [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.1mM"

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP,"

Phrase: "2mM Mg2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417500:MG2 [Gene or Genome]
   861   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "during 60min"

Phrase: "at 30C."
Processing 00000000.tx.71: The precipitates were washed and analyzed in SDS-PAGE. 

Phrase: "The precipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "analyzed in SDS-PAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]
Processing 00000000.tx.72: Gels were quantitatively analyzed using a PhosphorImager (Molecular Dynamics). 

Phrase: "Gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "quantitatively"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PhosphorImager"

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")."
Processing 00000000.tx.73: For immunoblotting experiments, cells were scraped in PBS, centrifuged (10min, 1000rpm), and solubilized in Laemmli sample buffer. 

Phrase: "For immunoblotting experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "scraped in PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0184933:scraped [Therapeutic or Preventive Procedure]
   790   C0444082:scraped [Body Substance]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(10min,"

Phrase: "1000rpm"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "solubilized in Laemmli sample buffer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0258024:Laemmli buffer [Organic Chemical]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.74: Blots were stained with mAb 9E10 (Myc tag) ascites fluid (1/1000 dilution) or mAb PS1-3 hybridoma supernatant (1/100 dilution) and affinity-purified goat anti-mouse peroxidase-conjugated antibodies (1/10,000; Bio-Rad), using the sensitive ECL system (Amersham). 

Phrase: "Blots"

Phrase: "were"

Phrase: "stained with mAb 9E10"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Myc tag) ascites fluid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0003964:Fluid, Ascites [Body Substance]
   812   C0005889:FLUID [Body Substance]
   812   C0302908:fluid [Substance]
   812   C0444611:Fluid [Qualitative Concept]
   812   C1704353:Fluid [Substance]

Phrase: "(1/1000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "mAb PS1-3 hybridoma supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1550101:Supernatant [Body Substance]

Phrase: "(1/100 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "affinity-purified goat anti-mouse peroxidase-conjugated antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   850   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   834 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1/10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "000"

Phrase: "; Bio-Rad"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the sensitive ECL system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Amersham"

Phrase: ")."
Processing 00000000.tx.75: Phosphoamino Acid Analysis Immunoprecipitated 32P-labeled PS were size-fractionated in SDS-PAGE, and labeled bands were localized by autoradiography. 

Phrase: "Phosphoamino Acid Analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0001128:Acid [Chemical]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "Immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "32P-labeled PS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "size-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "fractionated in SDS-PAGE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   770   C1979893:Fractionated [Qualitative Concept]

Phrase: "and"

Phrase: "labeled bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "localized by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0392752:Localized [Spatial Concept]
Processing 00000000.tx.76: The proteins were hydrolyzed in 6N HCl (110C, 90min). 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "hydrolyzed in 6N HCl (110C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1550070:6N HCL [Biomedical or Dental Material,Inorganic Chemical]
   806   C1561471:6N HCL [Intellectual Product]

Phrase: "90min"

Phrase: ")."
Processing 00000000.tx.77: The hydrolysate was supplemented with phosphoamino acid standards and analyzed by two-dimensional thin-layer electrophoresis at pH 1.9and 3.5 in the respective dimensions (28). 

Phrase: "The hydrolysate"

Phrase: "was"

Phrase: "supplemented with phosphoamino acid standards"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0001128:Acid [Chemical]
   760   C0038137:standards [Intellectual Product]
   760   C0175675:Standards [Qualitative Concept]
   760   C0202406:Acid [Laboratory Procedure]
   726   C0242295:Supplement [Food]
   726 E C1442989:Standard [Qualitative Concept]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]
   726 E C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "analyzed by two-dimensional thin-layer electrophoresis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0678631:thin-layer electrophoresis [Laboratory Procedure]
   804   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   778   C1705052:2-Dimensional [Spatial Concept]
   748   C0013855:Electrophoresis [Laboratory Procedure]
   748   C0205168:Thin [Qualitative Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0934502:Layer [Body Part, Organ, or Organ Component]
   748   C0936012:Analyzed [Research Activity]
   748   C1522408:Layer [Qualitative Concept]
   748   C1561599:Layer [Intellectual Product]

Phrase: "at pH 1.9and 3.5"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0601906:PH 3 [Pharmacologic Substance]
   840   C1412290:PH1 [Gene or Genome]
   804   C0020283:[pH] [Quantitative Concept]
   804   C0450407:ph+ [Finding]
   804   C0450408:ph++ [Finding]
   804   C0450409:ph+++ [Finding]

Phrase: "in the respective dimensions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439534:Dimensions [Quantitative Concept]
   755 E C1707753:Dimensionality [Spatial Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.78: Phosphoserine, phosphothreonine, and phosphotyrosine were localized using ninhydrin staining, and the radioactive phosphoamino acid residues were visualized by autoradiography. 

Phrase: "Phosphoserine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031721:Phosphoserine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "phosphothreonine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031724:Phosphothreonine [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ninhydrin staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "the radioactive phosphoamino acid residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "visualized by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.79: Immunocytochemistry Fibroblasts were grown on coverslips coated with mouse collagen IV (Collaborative Biomedical Products; 1g/cm2). 

Phrase: "Immunocytochemistry Fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "grown on coverslips"

Phrase: "coated with mouse collagen IV (Collaborative Biomedical Products"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C0009333:Collagen IV [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0009325:Collagen product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
           Collagen
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0282116:collaborative [Social Behavior]
   744   C1167364:collagen [Cell Component]
   744   C1514468:Products [Entity]
   744   C1522408:Coated [Qualitative Concept]
   744   C1879848:Biomedical [Biomedical Occupation or Discipline]
   711 E C0453946:Coat [Manufactured Object]
   711 E C1704444:Product [Quantitative Concept]
   711 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "; 1g/cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439479:cm2 [Quantitative Concept]
   861   C0555206:CM2 [Congenital Abnormality]

Phrase: ")."
Processing 00000000.tx.80: Transfected COS-1 or CHO cells were cultured in Lab-TEK chamber slides (Nunc). 

Phrase: "Transfected COS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0376702:COS-1 [Cell]
   827   C0454802:Cos [Geographic Area]

Phrase: "or"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "in Lab-TEK chamber slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0444330:slides [Research Device]
   771 E C1705201:Slide [Manufactured Object]

Phrase: "(Nunc"

Phrase: ")."
Processing 00000000.tx.81: Cells were washed twice in PBS, fixed in 4% formaldehyde in PBS for 10min at room temperature, and washed three times in PBS and once in TBS. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "fixed in 4% formaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "for 10min"

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "washed three times in PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "once in TBS."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036082:Saline [Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]
   760   C1720092:Once [Intellectual Product]
   760   C1948045:Once [Temporal Concept]
Processing 00000000.tx.82: Cells were permeabilized with 0.02% (v/v) Triton X-100 in TBS for 20min or with 0.2% (w/v) saponin for 10min and washed with 0.1% Tween 20in TBS. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "permeabilized with 0.02%"

Phrase: "(v/v) Triton X-100 in TBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   764   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   742   C0242759:Triton [Geographic Area]

Phrase: "for 20min"

Phrase: "or with 0.2%"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "saponin for 10min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520481:Saponin [Steroid]
   790   C0885750:saponin [Organic Chemical]

Phrase: "and"

Phrase: "washed with 0.1% Tween 20in TBS."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   742   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0036082:Saline [Substance]
   742   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0814229:TRI [Intellectual Product]
   742   C1548982:Washed [Idea or Concept]
   708 E C0441648:Wash [Activity]
Processing 00000000.tx.83: Nonspecific binding was blocked with 0.2% cold water fish gelatin, 2% bovine serum albumin, and 2% fetal calf serum (blocking buffer). 

Phrase: "Nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "blocked with 0.2% cold water fish gelatin,"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   744   C0009264:Cold [Natural Phenomenon or Process]
   744   C0009443:Cold [Disease or Syndrome]
   744   C0016163:Fish [Fish]
   744   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   744   C0028778:Blocked [Pathologic Function]
   744   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   744   C0234192:Cold [Physiologic Function]
   744   C0332206:Blocked [Functional Concept]
   744   C0599638:WATER [Substance]
   744   C1145617:Gelatin [Food]
   744   C1550678:Water [Inorganic Chemical]
   744   C2349190:Fish [Food]
   744   C2700184:FISH [Qualitative Concept]
   744   C2983591:BLOCKED [Research Activity]
   711 E C1533157:Block [Substance]
   711 E C1706084:Block [Geographic Area]
   711 E C2828370:Block [Quantitative Concept]

Phrase: "2% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   861   C0728877:serum albumin [Laboratory or Test Result]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007452:Bovine [Mammal]
   812   C0229671:Serum [Body Substance]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "2% fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "(blocking buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.84: Cells were probed with affinity-purified primary antibody 519(1:25) or with immune serum (1:400). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "probed with affinity-purified primary antibody 519"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C0003255:Antibody Affinity [Molecular Function]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0205225:Primary [Qualitative Concept]
   748   C0439631:Primary [Therapeutic or Preventive Procedure]
   748   C1510827:Affinity [Natural Phenomenon or Process]
   748   C1998793:Purified [Functional Concept]
   714   C0182400:Probe [Medical Device]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714   C3536729:Probe [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "25"

Phrase: ")"

Phrase: "or with immune serum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0020960:immune serum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0229671:Serum [Body Substance]
   770   C0439662:Immune [Functional Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "400"

Phrase: ")."
Processing 00000000.tx.85: Appropriate FITC- and TRITC-conjugated anti-mouse, anti-rat, and anti-rabbit antibodies (Sigma) were used at 1/400 dilution. 

Phrase: "Appropriate FITC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "TRITC-conjugated anti-mouse, anti-rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:Rat, NOS [Mammal]
   799   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "anti-rabbit antibodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0034493:Rabbit [Mammal]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "at 1/400 dilution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0079240:Dilution [Laboratory Procedure]
   812   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.86: Preparations were viewed on a Nikon Diaphot 300or a Zeiss Axiophot UV microscope. 

Phrase: "Preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "viewed on a Nikon Diaphot 300or"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0449911:View [Spatial Concept]

Phrase: "a Zeiss Axiophot UV microscope."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0181839:Microscope [Medical Device]
   812   C1706379:Microscope [Medical Device]
Processing 00000000.tx.87: Digitized immunofluorescence images were obtained using an LSM419-inverted laser-scanning confocal microscope (Zeiss Inc.) and processed using NIH Image software. 

Phrase: "Digitized immunofluorescence images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an LSM419-inverted laser-scanning confocal microscope"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   827   C1626420:Confocal microscope [Medical Device]
   799   C0023089:Laser [Manufactured Object]
   799   C0034606:Scanning [Diagnostic Procedure]
   799   C0181839:Microscope [Medical Device]
   799   C0441633:Scanning [Diagnostic Procedure]
   799   C0458142:Laser [Phenomenon or Process]
   799   C1023865:Laser [Plant]
   799   C1706315:Laser [Medical Device]
   799   C1706379:Microscope [Medical Device]
   766 E C2826292:SCAN [Finding]

Phrase: "(Zeiss"

Phrase: "Inc.)"

Phrase: "and"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NIH Image software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.88: Selective permeabilization of the plasma membrane was obtained by incubating fixed cells in 10mM Pipes buffer (pH 6.8) containing 0.3M sucrose, 0.1M KCl, 2.5mM MgCl2, 1mM EDTA, 5g/ml digitonin during 15min at 4C (29). 

Phrase: "Selective permeabilization of the plasma membrane"

Phrase: "was"

Phrase: "obtained by incubating fixed cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C1253961:Fixed cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1439852:incubating [Laboratory Procedure]
   760   C2827483:Fixed [Body Substance]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1706701:Obtain [Activity]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in 10mM Pipes buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 6.8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.3M sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "0.1M KCl,"

Phrase: "2.5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "5g/ml digitonin during 15min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.89: Cells were washed with PBS and further processed. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "processed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.90: A rat monoclonal antibody against the KDEL sequence (30, 31) was used to demonstrate permeabilization of the endoplasmic reticulum membrane. 

Phrase: "A rat monoclonal antibody against the KDEL sequence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0746619:monoclonal [Finding]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "permeabilization of the endoplasmic reticulum membrane."
Processing 00000000.tx.91: RESULTS Immunocytochemical Localization of Presenilin 1in the Endoplasmic Reticulum and the Golgi Apparatus The subcellular localization of the presenilins was investigated in permeabilized and fixed fibroblasts using affinity-purified polyclonal antibody 519raised against the peptide KDGQLIYTPFTEDTE, which is a conserved sequence in the second loop domain of PS1 and PS2 (9, 12). 

Phrase: "RESULTS Immunocytochemical Localization of Presenilin 1in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "the Endoplasmic Reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "the Golgi Apparatus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]

Phrase: "The subcellular localization of the presenilins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "investigated in permeabilized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292732:investigated [Functional Concept]

Phrase: "and"

Phrase: "fixed fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "affinity-purified polyclonal antibody 519raised against the peptide KDGQLIYTPFTEDTE,"

Phrase: "which"

Phrase: "is"

Phrase: "a conserved sequence in the second loop domain of PS1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0009802:Conserved Sequence [Nucleotide Sequence]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "PS2"

Phrase: "(9,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.92: A fine reticular staining in the cytoplasm and a more pronounced perinuclear staining was observed in the cells (Fig. 1A), which partially colocalized with the staining obtained with a mAb against BiP, an endoplasmic reticulum marker. 

Phrase: "A fine reticular staining in the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced"

Phrase: "perinuclear staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "observed in the cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "which partially"

Phrase: "colocalized with the staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "obtained with a mAb"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "against BiP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "an endoplasmic reticulum marker."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005516:Marker [Clinical Attribute]
   734   C0014239:Endoplasmic Reticulum [Cell Component]
Processing 00000000.tx.93: Preabsorption of antibody 519with the peptide antigen resulted in loss of staining, demonstrating the specificity of the observed signals (Fig. 1C). 

Phrase: "Preabsorption of antibody 519with"

Phrase: "the peptide antigen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigen [Immunologic Factor]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "resulted in loss of staining,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1517945:Loss [Quantitative Concept]
   760   C1704680:Staining [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "demonstrating"

Phrase: "the specificity of the observed signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.94: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.95: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.96: Immunofluorescent staining of PS1/2 in untransfected fibroblasts. 

Phrase: "Immunofluorescent staining of PS1/2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0183489:Immunofluorescent stain [Indicator, Reagent, or Diagnostic Aid]
           Immunofluorescent
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in untransfected fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.97: Fibroblasts were fixed with formaldehyde and permeabilized with Triton X-100. 

Phrase: "Fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "fixed with formaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "permeabilized with Triton X-100."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   806   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   760   C0242759:Triton [Geographic Area]
Processing 00000000.tx.98: Cells were incubated with affinity-purified rabbit antibody 519against the loop 2domain of PS1/2 (panel A) and mouse mAb against BiP (panel B), followed by appropriate TRITC- and FITC-conjugated secondary antibodies. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with affinity-purified rabbit antibody 519against"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003255:Antibody Affinity [Molecular Function]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034493:Rabbit [Mammal]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1510827:Affinity [Natural Phenomenon or Process]
   748   C1998793:Purified [Functional Concept]

Phrase: "the loop 2domain of PS1/2"

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "A)"

Phrase: "and"

Phrase: "mouse mAb against BiP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0443737:Monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0700271:monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C1317659:Protein.monoclonal [Laboratory or Test Result]
   783   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]

Phrase: "(panel B"

Phrase: ")"

Phrase: ","

Phrase: "followed by appropriate TRITC-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0076308:TRITC [Organic Chemical,Pharmacologic Substance]
   770   C1548787:Appropriate [Qualitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "FITC-conjugated secondary antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.99: Presenilin staining is observed in the cytoplasm as a reticular pattern (A) that partially colocalizes with the staining obtained with the mAb against the endoplasmic reticulum marker BiP (B). 

Phrase: "Presenilin staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "observed in the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C1441672:Observed [Functional Concept]

Phrase: "as a reticular pattern"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335761:Reticular Pattern [Finding]
   861   C0449774:Pattern [Spatial Concept]

Phrase: "(A)"

Phrase: "that partially"

Phrase: "colocalizes with the staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "obtained with the mAb"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "against the endoplasmic reticulum marker BiP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.100: Panel C, fibroblasts stained with antibody 519preabsorbed with peptide revealed only weak background fluorescence. 

Phrase: "Panel C,"

Phrase: "fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "stained with antibody 519preabsorbed"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "with peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "only weak background fluorescence."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.101: [View Larger Version of this Image (32K GIF file)] The same, lacelike network was seen in COS-1 cells transfected with plasmids containing the cDNA for PS1 and using antiserum B14 against peptide NDNRERQEHNDRRS in the amino-terminal domain of PS1 or antiserum B16 against peptide EGDPEAQRRVSKNSKY in the hydrophilic loop domain of PS1 (Fig. 2, a and c). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(32K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "The same, lacelike network"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "was"

Phrase: "seen in COS-1 cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   862   C1257857:COS-1 Cells [Cell]
   806   C0376702:COS-1 [Cell]
           COS Cells
   760   C0007634:Cells [Cell]
   760   C0205397:Seen [Qualitative Concept]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C0042789:see [Organism Function]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1947903:See [Activity]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the cDNA for PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antiserum B14 against peptide NDNRERQEHNDRRS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1417627:B14 [Gene or Genome]

Phrase: "in the amino-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "antiserum B16 against peptide EGDPEAQRRVSKNSKY"

Phrase: "in the hydrophilic loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "c)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.102: Untransfected COS-1 cells remained negative under the experimental conditions used, probably because of the very low levels of endogeneous PS present in these cells (see below). 

Phrase: "Untransfected COS-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C1257857:COS-1 Cells [Cell]
   875   C0376702:COS Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "remained"

Phrase: "negative under the experimental conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205160:Negative [Qualitative Concept]
   760   C1513916:Negative [Finding]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "probably because of the very low levels of endogeneous PS present"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   756   C0442811:Very low [Finding]
   754   C1444704:Probably present [Finding]
   738   C0150312:Present [Quantitative Concept]
   738   C0205251:low [Qualitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C0442824:Very [Qualitative Concept]
   738   C0449450:Present [Idea or Concept]
   738   C0750492:Probably [Idea or Concept]
   738   C1299352:Low [Qualitative Concept]
   738   C1418867:Ps [Gene or Genome]
   738   C1518860:PS [Geographic Area]
   738   C1550472:low [Idea or Concept]
   738   C1552158:Ps [Body Part, Organ, or Organ Component]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.103: The same pattern of staining was observed with monoclonal antibody IID8 (32) against Serca 2a Ca2+-ATPase (results not shown), and with antibodies against transfected reticulon/NSP (Fig. 2b). 

Phrase: "The same pattern of staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C0449778:Pattern of staining [Spatial Concept]
   760   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "observed with monoclonal antibody IID8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   760   C1441672:Observed [Functional Concept]

Phrase: "(32"

Phrase: ")"

Phrase: "against Serca 2a Ca2+-ATPase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C1515981:And [Idea or Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against transfected reticulon/NSP (Fig. 2b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450354:2b [Intellectual Product]
   804   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.104: Both proteins are located in the endoplasmic reticulum and the Golgi apparatus (24). 

Phrase: "Both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "located in the endoplasmic reticulum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the Golgi apparatus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.105: The distribution of PS1 and reticulon/NSP remained identical in double transfected cells (compare panels a and b in Fig. 2). 

Phrase: "The distribution of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "reticulon/NSP"

Phrase: "remained"

Phrase: "identical in double transfected cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: "and"

Phrase: "b in Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0045550:B 2 [Organic Chemical,Pharmacologic Substance]
   770   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.106: Transfected APP (Fig. 2e) and transfected furin (Fig. 2d), in contrast, were mainly found in the Golgi apparatus, as shown previously (33, 34). 

Phrase: "Transfected APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(Fig. 2e"

Phrase: ")"

Phrase: "and"

Phrase: "transfected furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919550:FURIN [Gene or Genome]

Phrase: "(Fig. 2d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "in contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "were"

Phrase: "mainly"

Phrase: "found in the Golgi apparatus,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   760   C0150312:Found [Quantitative Concept]
   760   C0243111:apparatus [Manufactured Object]
   760   C1947951:Apparatus [Anatomical Structure]
   726 E C0243095:Find [Finding]

Phrase: "as"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "(33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.107: Similar results were obtained in CHO cells (results not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in CHO cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.109: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.110: Immunofluorescent staining of PS1 in transfected COS cells. 

Phrase: "Immunofluorescent staining of PS1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   816   C0183489:Immunofluorescent stain [Indicator, Reagent, or Diagnostic Aid]
           Immunofluorescent
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in transfected COS cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.111: COS-1 cells were double transfected with plasmids coding for PS1 and reticulon/NSP (a and b) or single transfected with plasmids coding for PS1, amyloid precursor protein, or furin (c, d, and e). 

Phrase: "COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transfected with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "coding for PS1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0009219:Coding [Occupational Activity]
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]
   756 E C0805701:Code [Intellectual Product]

Phrase: "and"

Phrase: "reticulon/NSP ("

Phrase: "a"

Phrase: "and"

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037179:Single [Population Group]
  1000   C0087136:single [Finding]
  1000   C0205171:Single [Quantitative Concept]

Phrase: "transfected with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "coding for PS1,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0009219:Coding [Occupational Activity]
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]
   756 E C0805701:Code [Intellectual Product]

Phrase: "amyloid precursor protein,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "(c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "e"

Phrase: ")."
Processing 00000000.tx.112: Cells were fixed with formaldehyde and permeabilized with saponin. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed with formaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "permeabilized with saponin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520481:Saponin [Steroid]
   790   C0885750:saponin [Organic Chemical]
Processing 00000000.tx.113: Immunostaining was done with antiserum B14 against the amino-terminal domain of PS1 (a) or B16 against the loop domain of PS1 (c), with a mix of monoclonal antibodies MON160-162 against reticulon/NSP (b), or MON148 and 152against furin (d), or mAb 22C11 against amyloid precursor protein (e), followed by the appropriate TRITC-conjugated (red) or FITC-conjugated (green) secondary antibodies. 

Phrase: "Immunostaining"

Phrase: "was"

Phrase: "done with antiserum B14"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1272695:Done [Qualitative Concept]
   770   C1417627:B14 [Gene or Genome]
   770   C2746065:Done [Temporal Concept]

Phrase: "against the amino-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(a)"

Phrase: "or"

Phrase: "B16 against the loop domain of PS1"

Phrase: "(c),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "with a mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205430:Mix [Functional Concept]
  1000   C1421951:MIX [Gene or Genome]
  1000   C1720722:Mix [Qualitative Concept]

Phrase: "of monoclonal antibodies MON160-162"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0746619:monoclonal [Finding]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against reticulon/NSP (b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1504722:NSP-B [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "MON148"

Phrase: "and"

Phrase: "152against furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919550:FURIN [Gene or Genome]

Phrase: "("

Phrase: "d)"

Phrase: ","

Phrase: "or"

Phrase: "mAb 22C11 against amyloid precursor protein"

Phrase: "(e"

Phrase: ")"

Phrase: ","

Phrase: "followed by the appropriate TRITC-conjugated"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0076308:TRITC [Organic Chemical,Pharmacologic Substance]
   753   C0522529:Conjugated [Spatial Concept]
   753   C1548787:Appropriate [Qualitative Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "or"

Phrase: "FITC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "conjugated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522529:Conjugated [Spatial Concept]
   928 E C1160466:conjugation [Cell Function]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "secondary antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.114: Notice the fine reticular pattern obtained with PS1 antibodies in panels a and c, which distributes with reticulon/NSP (panel b) in double transfected cells. 

Phrase: "Notice"

Phrase: "the fine reticular pattern"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1335761:Reticular Pattern [Finding]
   827   C0449774:Pattern [Spatial Concept]

Phrase: "obtained with PS1 antibodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1301820:Obtained [Functional Concept]
   770   C1418985:PS1 [Gene or Genome]
   770   C2986918:PS1 [Gene or Genome]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737 E C1706701:Obtain [Activity]

Phrase: "in panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: "and"

Phrase: "c,"

Phrase: "which"

Phrase: "distributes with reticulon/NSP (panel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441833:Panel [Idea or Concept]
   760   C1704711:Distribute [Functional Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]

Phrase: "b) in double transfected cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0004561:B-Cells [Cell]
   760   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.115: Panel e demonstrates that amyloid precursor protein is located mainly in the Golgi apparatus, similar to furin (panel d). 

Phrase: "Panel e"

Phrase: "demonstrates"

Phrase: "that amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "located"

Phrase: "mainly in the Golgi apparatus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   760   C0243111:apparatus [Manufactured Object]
   760   C1947951:Apparatus [Anatomical Structure]

Phrase: "similar to furin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "d)."
Processing 00000000.tx.116: [View Larger Version of this Image (128K GIF file)] Biosynthesis of the Presenilins Metabolic labeling of untransfected or "mock" transfected COS-1 or CHO cells using [35S]methionine, followed by immunoprecipitation of the cell extracts using antibodies 519,B14, or B17 and resolution of the immunoprecipitates in SDS-PAGE, yielded no signals (Fig. 3A, lane 4) or, after prolonged exposures (2weeks and more), only nonspecific signals in autoradiography (results not shown). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(128K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Biosynthesis of the Presenilins Metabolic labeling of untransfected or """
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0005572:biosynthesis [Functional Concept]
   742   C0220781:Biosynthesis [Biologic Function]

Phrase: "mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: """ transfected COS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0376702:COS-1 [Cell]
   827   C0454802:Cos [Geographic Area]

Phrase: "or"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[35S"

Phrase: "]methionine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "followed by immunoprecipitation of the cell extracts"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0007592:Cell Extracts [Cell Component]
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0007634:Cell [Cell]
   748   C0021069:Immunoprecipitation [Laboratory Procedure]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1719822:Follow [Intellectual Product]
   714   C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies 519,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "B14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417627:B14 [Gene or Genome]

Phrase: "or"

Phrase: "B17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414132:B17 [Gene or Genome]
  1000   C1417638:B17 [Gene or Genome]

Phrase: "and"

Phrase: "resolution of the immunoprecipitates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514893:Resolution [Idea or Concept]
   770   C1706463:Resolution [Quantitative Concept]
   770   C2699488:Resolution [Conceptual Entity]

Phrase: "in SDS-PAGE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "yielded"

Phrase: "no signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "(Fig. 3A,"

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: ","

Phrase: "after"

Phrase: "prolonged exposures"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0274281:exposures [Injury or Poisoning]
   861   C0439590:Prolonged [Temporal Concept]
   861   C0728853:exposures [Phenomenon or Process]
   827 E C0332157:Exposure [Clinical Attribute]

Phrase: "(2weeks"

Phrase: "and"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "only nonspecific signals in autoradiography"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.117: Immunoprecipitation of detergent extracts of COS-1 cells transfected with plasmids containing the cDNA of wild type PS1, in contrast, yielded strong specific signals of radiolabeled protein migrating with an apparent molecular mass of 45kDa (Fig. 3A, lanes 1-3). 

Phrase: "Immunoprecipitation of detergent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "extracts of COS-1 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C1257857:COS-1 Cells [Cell]
   806   C0376702:COS-1 [Cell]
           COS Cells
   781   C0007592:Cell Extracts [Cell Component]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C2828366:Extract [Substance]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the cDNA of wild type PS1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "yielded"

Phrase: "strong specific signals of radiolabeled protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710082:Signal [Phenomenon or Process]

Phrase: "migrating with an apparent molecular mass of 45kDa"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   744   C0232902:migrating [Functional Concept]
   744   C0577559:Mass [Finding]
   744   C0750489:apparent [Idea or Concept]
   744   C1306372:*Mass [Quantitative Concept]
   744   C1521991:Molecular [Qualitative Concept]

Phrase: "(Fig. 3A,"

Phrase: "lanes 1-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.118: Diffuse protein bands with masses between 100and 250kDa were observed to a variable extent (Fig. 3A). 

Phrase: "Diffuse protein bands with masses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "between 100and 250kDa"

Phrase: "were"

Phrase: "observed to a variable extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439792:Extent [Spatial Concept]
   760   C0439828:Variable [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.119: Similar results were obtained with PS2 cDNA. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with PS2 cDNA."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.120: The main PS2 species migrated, however, slightly more slowly than PS1, resulting in an apparent mass of 50kDa (see below). 

Phrase: "The main PS2 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: ","

Phrase: "however,"

Phrase: "slightly more slowly than PS1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439834:Slowly [Qualitative Concept]
   760   C0750482:Slightly [Idea or Concept]
   760   C1418985:PS1 [Gene or Genome]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "resulting in an apparent mass of 50kDa"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0332294:Resulting in [Functional Concept]
   748   C0577559:Mass [Finding]
   748   C0678226:resulting [Functional Concept]
   748   C0750489:apparent [Idea or Concept]
   748   C1306372:*Mass [Quantitative Concept]
   748   C3152252:Mass [Quantitative Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.121: Unrelated polyclonal antibodies, or untransfected cells did not yield these bands, while immunoblots of COS-1 cells transfected with Myc-tagged PS1 and stained with the Myc tag-specific mAb 9E10 revealed again the pronounced smearing (Fig. 3B). 

Phrase: "Unrelated polyclonal antibodies,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "untransfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "yield"

Phrase: "these bands,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "while"

Phrase: "immunoblots of COS-1 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "transfected with Myc-tagged PS1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PS1 [Gene or Genome]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708632:Tagged [Qualitative Concept]
   760   C2986918:PS1 [Gene or Genome]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "stained with the Myc tag-specific mAb 9E10"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   764   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0037293:Tag [Neoplastic Process]
   742   C0181496:Tag [Manufactured Object]
   742   C0205369:Specific [Qualitative Concept]
   742   C0746619:monoclonal [Finding]
   742   C1552740:specific [Intellectual Product]
   742   C1710492:TAG [Gene or Genome]
   742   C2986582:Stained [Qualitative Concept]
   708 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "again"

Phrase: "the pronounced smearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0444186:smearing [Diagnostic Procedure]
   827 E C1947932:Smear [Activity]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.122: This result clearly demonstrated that the 100-250-kDa protein smears consisted of PS protein, either associated or not associated with other proteins. 

Phrase: "This result clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the 100-250-kDa protein smears"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0444186:smears [Diagnostic Procedure]
   771 E C1947932:Smear [Activity]

Phrase: "consisted of PS protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418867:Ps [Gene or Genome]
   770   C1518860:PS [Geographic Area]
   770   C1552158:Ps [Body Part, Organ, or Organ Component]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "either associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0332281:Associated [Qualitative Concept]
   827 E C0750490:Associate [Idea or Concept]
   827 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with other proteins."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.123: Essential similar patterns were observed when PS1 FAD1 (Ala-246 Glu) or PS1 NIH2 (Cys-410 Tyr) were expressed (Fig. 3A). 

Phrase: "Essential similar patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "PS1 FAD1"

Phrase: "(Ala-246 Glu)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0051079:Ala-Glu [Amino Acid, Peptide, or Protein]
   827   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "PS1 NIH2"

Phrase: "(Cys-410 Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1421250:TYR [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "expressed"

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.124: These clinical mutations (12) therefore do not cause major alterations in the biosynthesis of PS1 protein when overexpressed in COS-1 cells (Fig. 3A). 

Phrase: "These clinical mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(12"

Phrase: ")"

Phrase: "therefore"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "major alterations in the biosynthesis of PS1 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1515926:Alteration [Idea or Concept]

Phrase: "when"

Phrase: "overexpressed in COS-1 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C1257857:COS-1 Cells [Cell]
   806   C0376702:COS-1 [Cell]
           COS Cells
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1514559:overexpress [Genetic Function]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.125: Independent experiments performed in CHO cells confirmed completely these results (results not shown). 

Phrase: "Independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed in CHO cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0884358:Performed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.127: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.128: Biosynthesis of PS1 protein in COS-1 cells. 

Phrase: "Biosynthesis of PS1 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0597295:Protein Biosynthesis [Molecular Function]
   770   C0005572:biosynthesis [Functional Concept]
   770   C0220781:Biosynthesis [Biologic Function]

Phrase: "in COS-1 cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.129: Panel A, COS-1 cells were transfected with constructs containing the cDNA coding for wild type PS1 (PS1 WT), PS1 FAD1 (Ala-246 Glu), PS1 NIH2 (Cys-410 Tyr), or with expression vector alone (pSG5 control). 

Phrase: "Panel A,"

Phrase: "COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2827421:Construct [Classification]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the cDNA coding for wild type PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0009219:Coding [Occupational Activity]

Phrase: "(PS1 WT), PS1 FAD1"

Phrase: "(Ala-246 Glu),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0051079:Ala-Glu [Amino Acid, Peptide, or Protein]
   827   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PS1 NIH2"

Phrase: "(Cys-410 Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1421250:TYR [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "or with expression vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(pSG5 control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.130: Cells were metabolically labeled with [35S]methionine for 4h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "metabolically"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[35S"

Phrase: "]methionine for 4h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.131: Cells were solubilized, and PS1 was immunoprecipitated with antiserum B17 (1/250). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "solubilized"

Phrase: ","

Phrase: "and"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated with antiserum B17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1414132:B17 [Gene or Genome]
   770   C1417638:B17 [Gene or Genome]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(1/250"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.132: Immunoprecipitates were resolved by 4-20% gradient SDS-PAGE. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "resolved by 4-20% gradient SDS-PAGE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   774   C1538569:PAGE-4 [Gene or Genome]
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1514893:Resolved [Idea or Concept]
   748   C1704732:Page [Intellectual Product]
   748   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.133: Molecular size markers are indicated at the left in kDa. 

Phrase: "Molecular size markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0596969:molecular size [Quantitative Concept]

Phrase: "are"

Phrase: "indicated at the left"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1444656:Indicated [Finding]
   770   C1552822:left [Functional Concept]

Phrase: "in kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.134: Panel B, Western blotting of COS-1cells transfected with PS1 containing amino-terminally inserted Myc epitope. 

Phrase: "Panel B,"

Phrase: "Western blotting of COS-1cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   790 E C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]

Phrase: "transfected with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "amino-terminally inserted Myc epitope."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003316:Epitope [Immunologic Factor]
Processing 00000000.tx.135: Cell extracts were electophoresed on a 4-20% gradient acrylamide gel and transferred to a nitrocellulose membrane. 

Phrase: "Cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "electophoresed on a 4-20% gradient acrylamide gel"

Phrase: "and"

Phrase: "transferred to a nitrocellulose membrane."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
Processing 00000000.tx.136: mAb 9E10 against the Myc epitope was used to detect PS1. 

Phrase: "mAb 9E10 against the Myc epitope"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.137: Panel C, combined immunoprecipitation and Western blotting of PS1 in untransfected COS cells. 

Phrase: "Panel C,"

Phrase: "combined immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Western blotting of PS1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "in untransfected COS cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.138: Detergent extracts of 10106 untransfected COS-1 cells were made, and PS1 was immunoprecipitated using antiserum B13 (N-term) or B17 (Loop). 

Phrase: "Detergent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011740:Detergent [Chemical Viewed Functionally]

Phrase: "extracts of 10106 untransfected COS-1 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   814   C1257857:COS-1 Cells [Cell]
   778   C0376702:COS-1 [Cell]
           COS Cells
   757   C0007592:Cell Extracts [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0454802:Cos [Geographic Area]
   748   C2828366:Extract [Substance]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antiserum B13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417625:B13 [Gene or Genome]

Phrase: "(N-term"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "B17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414132:B17 [Gene or Genome]
  1000   C1417638:B17 [Gene or Genome]

Phrase: "(Loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.139: In lanes 1, 3, 5, and 7, 0.5105 COS-1 cells transfected with wild type PS1 were added to the untransfected cells. 

Phrase: "In lanes 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "7,"

Phrase: "0.5105 COS-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C1257857:COS-1 Cells [Cell]
   853   C0376702:COS Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wild type PS1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1418985:PS1 [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "were"

Phrase: "added to the untransfected cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1524062:Added [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1883712:Add [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.140: Immunoprecipitated material was resolved in 4-20% gradient SDS-PAGE and transferred to a nitrocellulose filter. 

Phrase: "Immunoprecipitated material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "resolved in 4-20% gradient SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   774   C1538569:PAGE-4 [Gene or Genome]
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1514893:Resolved [Idea or Concept]
   748   C1704732:Page [Intellectual Product]
   748   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "transferred to a nitrocellulose filter."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0180860:Filter [Manufactured Object]
   760   C0348011:transferred [Functional Concept]
   760   C0581406:Filter [Medical Device]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C1522664:Filter [Intellectual Product]
   760   C1704449:Filter [Conceptual Entity]
   760   C1704684:Filter [Medical Device]
   760   C1875155:FILTER [Medical Device]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
Processing 00000000.tx.141: Filters were reacted with mAb PS1-3 and goat anti-mouse peroxidase-conjugated antibodies (lanes 1-4, indicated by PS1-3) or with goat anti-mouse peroxidase conjugated antibodies alone (lanes 5-8, Co). 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "reacted with mAb PS1-3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0746619:monoclonal [Finding]
   753   C1418985:PS1 [Gene or Genome]
   753   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "goat anti-mouse peroxidase-conjugated antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   876   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   859 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lanes 1-4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "indicated by PS1-3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PS1 [Gene or Genome]
   770   C1444656:Indicated [Finding]
   770   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: "or with goat anti-mouse peroxidase conjugated antibodies"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   767   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   750 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0018019:goat [Mammal]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0522529:Conjugated [Spatial Concept]
   744   C1265549:goat [Mammal]
   744   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   744   C1510458:Goat [Mammal]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(lanes 5-8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "Co"

Phrase: ")."
Processing 00000000.tx.142: The mobility of intact PS1 is indicated by an arrow at the right. 

Phrase: "The mobility of intact PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "is"

Phrase: "indicated by an arrow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]

Phrase: "at the right."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]
Processing 00000000.tx.143: [View Larger Version of this Image (24K GIF file)] Since the levels of endogeneous PS1 were not detectable using classical immunoprecipitation, a sensitive immunological "sandwich" type assay was developed. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(24K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "Since"

Phrase: "the levels of endogeneous PS1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "not detectable"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "classical immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "a sensitive immunological """
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205470:Immunological [Functional Concept]

Phrase: "sandwich"

Phrase: """ type assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "developed."
Processing 00000000.tx.144: PS1 was immunoprecipitated from detergent extracts of 10106 untransfected COS-1 cells using polyclonal PS1 antisera. 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated from detergent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011740:Detergent [Chemical Viewed Functionally]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "extracts of 10106 untransfected COS-1 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   814   C1257857:COS-1 Cells [Cell]
   778   C0376702:COS-1 [Cell]
           COS Cells
   757   C0007592:Cell Extracts [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0454802:Cos [Geographic Area]
   748   C2828366:Extract [Substance]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal PS1 antisera."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.145: A small amount of transfected cells (0.5105) was added to the positive control samples. 

Phrase: "A small amount of transfected cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "(0.5105"

Phrase: ")"

Phrase: "was"

Phrase: "added to the positive control samples."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C1883676:Positive Control [Conceptual Entity]
   753   C0243148:control [Qualitative Concept]
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C1524062:Added [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C2825490:Positive [Qualitative Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0370003:Sample [Substance]
   719 E C1883712:Add [Functional Concept]
   719   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.146: The immunoprecipitates were then resolved in SDS-PAGE electrophoresis and transferred to a nitrocellulose filter. 

Phrase: "The immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resolved in SDS-PAGE electrophoresis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C1514893:Resolved [Idea or Concept]
   760   C1704732:Page [Intellectual Product]
   760   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "transferred to a nitrocellulose filter."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0180860:Filter [Manufactured Object]
   760   C0348011:transferred [Functional Concept]
   760   C0581406:Filter [Medical Device]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C1522664:Filter [Intellectual Product]
   760   C1704449:Filter [Conceptual Entity]
   760   C1704684:Filter [Medical Device]
   760   C1875155:FILTER [Medical Device]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
Processing 00000000.tx.147: Immunoprecipitated PS1 was finally detected with mAb PS1-3 raised against peptide RRVSKNSKYNAESTERESQDTVAE in the loop domain of PS1. 

Phrase: "Immunoprecipitated PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "finally"

Phrase: "detected with mAb PS1-3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0442726:Detected [Finding]
   753   C0746619:monoclonal [Finding]
   753   C1418985:PS1 [Gene or Genome]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C2986918:PS1 [Gene or Genome]

Phrase: "raised against peptide RRVSKNSKYNAESTERESQDTVAE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0442818:Raised [Quantitative Concept]

Phrase: "in the loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.148: Weak signals representing intact endogeneous PS1 were revealed in untransfected COS-1 cells (Fig. 3C, lanes 2and 4). 

Phrase: "Weak signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "intact endogeneous PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "were"

Phrase: "revealed in untransfected COS-1 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C1257857:COS-1 Cells [Cell]
   790   C0376702:COS-1 [Cell]
           COS Cells
   753   C0007634:Cells [Cell]
   753   C0443289:Revealed [Qualitative Concept]
   753   C0454802:Cos [Geographic Area]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "lanes 2and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.149: Endogeneous PS1 migrated with the same mobility (45 kDa) as transfected PS1, as is best seen in the experiments using the amino-terminal domain-specific antiserum B13 (Fig. 3C, lane 2). 

Phrase: "Endogeneous PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "migrated with the same mobility"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0232902:Migrated [Functional Concept]
   760   C0425245:Mobility [Finding]
   760   C0445247:Same [Qualitative Concept]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "(45 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "as"

Phrase: "transfected PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "as is best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1522427:Best [Qualitative Concept]
   793 E C0205170:Well [Qualitative Concept]
   793 E C3146287:Well [Manufactured Object]

Phrase: "seen in the experiments"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0205397:Seen [Qualitative Concept]
   770   C0681814:Experiments [Research Activity]
   737 E C0042789:see [Organism Function]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947903:See [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the amino-terminal domain-specific antiserum B13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1417625:B13 [Gene or Genome]

Phrase: "(Fig. 3C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.150: Since mAb PS1-3 recognizes an epitope in the carboxyl-terminally located hydrophilic loop, the combination of these antibodies is expected to detect mainly intact PS1 (Fig. 3C, lane 2). 

Phrase: "Since"

Phrase: "mAb PS1-3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0746619:monoclonal [Finding]
   812   C1418985:PS1 [Gene or Genome]
   812   C2986918:PS1 [Gene or Genome]

Phrase: "recognizes"

Phrase: "an epitope in the carboxyl-terminally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003316:Epitope [Immunologic Factor]

Phrase: "located"

Phrase: "hydrophilic loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "the combination of these antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "is"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "mainly intact PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "(Fig. 3C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.151: With hydrophilic loop-specific antiserum B17, in contrast, relatively pronounced 18-30-kDa fragments were visualized together with intact PS1. 

Phrase: "With hydrophilic loop-specific antiserum B17,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1414132:B17 [Gene or Genome]
   804   C1417638:B17 [Gene or Genome]

Phrase: "in contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "relatively"

Phrase: "pronounced"

Phrase: "18-30-kDa fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "visualized together with intact PS1."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205266:Intact [Qualitative Concept]
   760   C0234621:Visualized [Functional Concept]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PS1 [Gene or Genome]
   760   C1554187:Intact [Idea or Concept]
   760   C1883357:Together [Qualitative Concept]
   760   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.152: These fragments represent most likely carboxyl-terminal fragments of presenilin (35). 

Phrase: "These fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "most likely carboxyl-terminal fragments of presenilin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0332255:fragments [Functional Concept]
   748   C0486805:Fragments [Body Substance]
   714 E C1708096:Fragment [Qualitative Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.153: Remarkably, the observed fragments were not, or only marginally, increased in COS-1 cells overexpressing PS1 (compare lanes 3and lane 4in Fig. 3C). 

Phrase: "Remarkably,"

Phrase: "the observed fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "or"

Phrase: "only marginally,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "increased in COS-1 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C1257857:COS-1 Cells [Cell]
   806   C0376702:COS-1 [Cell]
           COS Cells
   760   C0007634:Cells [Cell]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 3and lane 4in Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.154: Pulse-chase experiments on transfected CHO-cells (Fig. 4, A and C) and COS-1 cells (results not shown) further showed that the transfected 45-kDa PS1 species has a half-life of about 4h. 

Phrase: "Pulse-chase experiments on transfected CHO-cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the transfected 45-kDa PS1 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "has"

Phrase: "a half-life of about 4h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018517:Half-Life [Temporal Concept]
   753   C0376558:Life [Idea or Concept]
   753   C2825407:Half [Quantitative Concept]
Processing 00000000.tx.155: No fragments were seen at any time point of this assay, either with amino-terminal (B13) or hydrophilic loop-specific (B17) antisera. 

Phrase: "No fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "seen at any time point of this assay,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C2348792:Time Point [Temporal Concept]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0040223:Time [Temporal Concept]
   744   C0205397:Seen [Qualitative Concept]
   744   C0243073:assay [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1552961:Point [Quantitative Concept]
   744   C2347617:point [Quantitative Concept]
   744   C3541383:Time [Temporal Concept]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]

Phrase: "either with amino-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205088:Terminal [Temporal Concept]
   770   C1705314:Terminal [Manufactured Object]
   770   C1705315:Terminal [Spatial Concept]

Phrase: "(B13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417625:B13 [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "hydrophilic loop-specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]

Phrase: "(B17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414132:B17 [Gene or Genome]
  1000   C1417638:B17 [Gene or Genome]

Phrase: ")"

Phrase: "antisera."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.156: APP, immunoprecipitated from the same cell extracts (Fig. 4B), displayed a much faster turnover (half-life: 2h), indicating that the relative high expression of PS1 did not interfere with the normal turnover of APP. 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "immunoprecipitated from the same cell extracts"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007592:Cell Extracts [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0445247:Same [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C0301871:Immunoprecipitate [Immunologic Factor]
   719   C2828366:Extract [Substance]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a much faster turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031227:turnover [Quantitative Concept]
   827   C0243127:turnover [Functional Concept]
   827   C0443331:Turnover [Health Care Activity]

Phrase: "(half-life"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018517:Half-Life [Temporal Concept]
   861   C0376558:Life [Idea or Concept]
   861   C2825407:Half [Quantitative Concept]
   777 E C0595998:lives [Finding]

Phrase: ":"

Phrase: "2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the relative high expression of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with the normal turnover of APP."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0597297:Protein Turnover [Molecular Function]
   762   C0860902:normal protein [Finding]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0031227:turnover [Quantitative Concept]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205307:Normal [Qualitative Concept]
   742   C0243127:turnover [Functional Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0443331:Turnover [Health Care Activity]
   742   C0521102:Interfere [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   742   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.157: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 4. 

Phrase: "4."
Processing 00000000.tx.159: Pulse-chase metabolic labeling of PS1 in transfected CHO cells. 

Phrase: "Pulse-chase metabolic labeling of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1167624:Labeling [Mental Process]
   753   C1947902:Labeling [Manufactured Object]
   753   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "in transfected CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.160: CHO cells expressing stably human APP770 were transfected with PS1 and metabolically labeled with [35S]methionine during 10min in methionine-free medium. 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "stably human APP770"

Phrase: "were"

Phrase: "transfected with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "metabolically"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[35S"

Phrase: "]methionine during 10min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in methionine-free medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]
Processing 00000000.tx.161: Incorporated label was chased by incubation of the cells in complete medium for the indicated time. 

Phrase: "Incorporated label"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181496:Label [Manufactured Object]
   861   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "chased by incubation of the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in complete medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "for the indicated time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.162: PS1 was immunoprecipitated from the cell extracts using B13 (N-term) or B17 (Loop) antiserum and resolved by 4-20% gradient SDS-PAGE (panel A). 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated from the cell extracts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007592:Cell Extracts [Cell Component]
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
   726   C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "B13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417625:B13 [Gene or Genome]

Phrase: "(N-term"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "B17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414132:B17 [Gene or Genome]
  1000   C1417638:B17 [Gene or Genome]

Phrase: "(Loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: ")"

Phrase: "antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "resolved by 4-20% gradient SDS-PAGE (panel A"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   762   C1538569:PAGE-4 [Gene or Genome]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0441833:Panel [Idea or Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C1514893:Resolved [Idea or Concept]
   742   C1704732:Page [Intellectual Product]
   742   C1999270:Panel [Intellectual Product]
   742   C2699488:Resolved [Conceptual Entity]
   742   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.163: APP was consecutively immunoprecipitated from the same cell extracts using antibody 207(45, 47) and analyzed in 6% homogeneous SDS-PAGE. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "consecutively"

Phrase: "immunoprecipitated from the same cell extracts"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007592:Cell Extracts [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0445247:Same [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C0301871:Immunoprecipitate [Immunologic Factor]
   719   C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody 207"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(45,"

Phrase: "47"

Phrase: ")"

Phrase: "and"

Phrase: "analyzed in 6% homogeneous SDS-PAGE."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C0936012:Analyzed [Research Activity]
   753   C1704732:Page [Intellectual Product]
   753   C1881065:Homogeneous [Qualitative Concept]
Processing 00000000.tx.164: Notice the difference in turnover of transfected presenilin 1and transfected APP. 

Phrase: "Notice"

Phrase: "the difference in turnover of transfected presenilin 1and"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "transfected"

Phrase: "APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.165: Panel C displays a quantitative analysis (meanS.E.) of three independent pulse-chase experiments of PS1. 

Phrase: "Panel C"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a quantitative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "(meanS.E.) of three independent pulse-chase experiments"

Phrase: "of PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.166: Signals were quantitated using a PhosphorImager. 

Phrase: "Signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PhosphorImager."
Processing 00000000.tx.167: The points represent the fraction of PS1 synthesized during a 10-min pulse and remaining after the period of chase as indicated. 

Phrase: "The points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the fraction of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1264633:Fraction of [Quantitative Concept]
           Fraction
   770   C1554103:Fraction [Idea or Concept]

Phrase: "synthesized during a 10-min pulse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0456692:/10 min [Temporal Concept]
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C0702093:/min [Temporal Concept]
   753   C1883254:Synthesized [Activity]
   753   C1947910:Pulse [Phenomenon or Process]

Phrase: "and"

Phrase: "remaining after the period of chase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1527428:Remaining [Qualitative Concept]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.168: The results obtained for APP in two experiments are also displayed. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained for APP"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1301820:Obtained [Functional Concept]
   760   C1709634:Precursor [Idea or Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "in two experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "also"

Phrase: "displayed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]
Processing 00000000.tx.169: [View Larger Version of this Image (14K GIF file)] Posttranslational Modification and Aggregation of Presenilins The problem of the presenilin smears in SDS-PAGE was further investigated. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(14K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Posttranslational Modification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033666:Post-Translational Modification [Molecular Function]
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "Aggregation of Presenilins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "The problem of the presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033213:Problem [Finding]

Phrase: "smears in SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0444186:Smear [Diagnostic Procedure]
   770   C1704732:Page [Intellectual Product]
   770   C1947932:Smear [Activity]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.170: Enzymatic digestion of immunoprecipitated PS1 and PS2 protein with glycosidase F (3milliunits/l), O-glycanase (60nanounits/l), endoglycosidase H (60nanounits/l), sialidase (100nanounits/l), or combinations of these enzymes did not affect the mobility of the proteins, indicating that no glycosylation of PS1 and PS2 occurred (results not shown). 

Phrase: "Enzymatic digestion of immunoprecipitated PS1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0012238:Digestion [Organism Function]
   760   C2349986:Digestion [Research Activity]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "PS2 protein with glycosidase F (3milliunits/l), O-glycanase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0072523:PS2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C2945724:f-protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(60nanounits/l), endoglycosidase H (60nanounits/l), sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(100nanounits/l),"

Phrase: "or"

Phrase: "combinations of these enzymes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0453882:Combinations [Manufactured Object]
   737 E C0205195:Combination [Qualitative Concept]
   737 E C1947911:Combination [Physical Object]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the mobility of the proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "no glycosylation of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017982:glycosylation [Natural Phenomenon or Process]
   770   C0376322:Glycosylation [Molecular Function]

Phrase: "and"

Phrase: "PS2"

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.171: Digestions with heparinase (0.1milliunits/l), heparitinase (0.1milliunits/l), chondroitinase AC (5milliunits/l), and chondroitinase ABC (5milliunits/l) also had no effect on the mobility of the protein smears, indicating that PS1 is not modified by glycosaminoglycan chains (Fig. 5). 

Phrase: "Digestions with heparinase"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0012238:digestions [Organism Function]
   756 E C2349986:Digestion [Research Activity]
   718 E C0443277:Peptic [Functional Concept]

Phrase: "(0.1milliunits/l), heparitinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0121449:heparitinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(0.1milliunits/l), chondroitinase AC (5milliunits/l),"

Phrase: "and"

Phrase: "chondroitinase ABC (5milliunits/l) also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0008455:Chondroitinase ABC [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0020197:chondroitinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0700083:Chondroitinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C2248821:chondroitinase [Molecular Function]

Phrase: "had"

Phrase: "no effect on the mobility of the protein smears,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "indicating"

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modified by glycosaminoglycan chains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0205349:Modified By [Qualitative Concept]
   770   C0017973:Glycosaminoglycan [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0337112:chains [Manufactured Object]
   770   C0392747:Modified [Functional Concept]
   770   C1524075:Chains [Idea or Concept]
   770   C3536869:Glycosaminoglycan [Pharmacologic Substance]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.172: These negative results were independently confirmed by metabolic labeling experiments using [3H]glucosamine or [35S]O4. 

Phrase: "These negative results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "independently"

Phrase: "confirmed by metabolic labeling experiments"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0311400:Metabolic [Functional Concept]
   760   C0681814:Experiments [Research Activity]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1167624:Labeling [Mental Process]
   760   C1524026:Metabolic [Cell Function]
   760   C1947902:Labeling [Manufactured Object]
   760   C2707259:Metabolic [Clinical Attribute]
   760   C2827499:Labeling [Governmental or Regulatory Activity]
   726 E C0181496:Label [Manufactured Object]
   726 E C1456348:Confirm [Qualitative Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[3H]glucosamine or [35S"

Phrase: "]O4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416199:O4 [Gene or Genome]
  1000   C3541298:O4 [Immunologic Factor,Lipid]
Processing 00000000.tx.173: While both radioactive precursors were incorporated in proteins in the cell extracts of the labeled cells, no signal was obtained when transfected PS1 was immunoprecipitated (results not shown). 

Phrase: "While"

Phrase: "both radioactive precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "incorporated in proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "extracts of the labeled cells,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   781   C0007592:Cell Extracts [Cell Component]
   760   C0007634:Cells [Cell]
   760   C1708632:Labeled [Qualitative Concept]
   760   C2828366:Extract [Substance]
   760   C3282337:Cells [Cell]
   726 E C0181496:Label [Manufactured Object]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "no signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "transfected PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.174: Experiments using [3H]palmitic or [3H]myristic acid demonstrated also that the presenilins did not incorporate fatty acids. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]palmitic or [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]myristic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027138:Myristic Acid [Biologically Active Substance,Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "demonstrated"

Phrase: "also"

Phrase: "that"

Phrase: "the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "incorporate"

Phrase: "fatty acids."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.175: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.176: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.177: Presenilins are not modified by glycosaminoglycan chains. 

Phrase: "Presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modified by glycosaminoglycan chains."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0205349:Modified By [Qualitative Concept]
   770   C0017973:Glycosaminoglycan [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0337112:chains [Manufactured Object]
   770   C0392747:Modified [Functional Concept]
   770   C1524075:Chains [Idea or Concept]
   770   C3536869:Glycosaminoglycan [Pharmacologic Substance]
Processing 00000000.tx.178: PS1 was immunoprecipitated using serum B16 from metabolically labeled COS-1 cells transfected with wild type PS1 and digested with heparinase, heparitinase, chondroitinase ABC, or chondroitinase AC. 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "serum B16 from metabolically labeled COS-1 cells"

Phrase: "transfected with wild type PS1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1418985:PS1 [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "digested with heparinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0062507:Heparinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0868946:digested [Physiologic Function]

Phrase: "heparitinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0121449:heparitinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "chondroitinase ABC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008455:Chondroitinase ABC [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "chondroitinase AC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244533:chondroitinase AC [Molecular Function]
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]
Processing 00000000.tx.179: Digested material was resolved in 12% homogeneous SDS-PAGE. 

Phrase: "Digested material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "resolved in 12% homogeneous SDS-PAGE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C1514893:Resolved [Idea or Concept]
   753   C1704732:Page [Intellectual Product]
   753   C1881065:Homogeneous [Qualitative Concept]
   753   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.180: The activity of the heparinase and heparitinase was confirmed using proteoglycans immunopurified from fibroblasts (50). 

Phrase: "The activity of the heparinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1323962:heparinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "heparitinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0121449:heparitinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "proteoglycans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033692:Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "immunopurified from fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0016030:Fibroblasts [Cell]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.181: The activity of chondroitinase ABC and AC was demonstrated using a test solution of chondroitinesulfate which was clarified after addition of the enzymes. 

Phrase: "The activity of chondroitinase ABC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   844   C2247535:chondroitinase ABC activity [Molecular Function]
   844   C2247540:chondroitinase ABC activity [Molecular Function]
   797   C1150920:chondroitinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "AC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "was"

Phrase: "demonstrated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a test solution of chondroitinesulfate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0022885:Test [Laboratory Procedure]
   760   C0037633:Solution [Substance]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "which"

Phrase: "was"

Phrase: "clarified after addition of the enzymes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0014442:Enzymes [Enzyme,Organic Chemical]
   753   C0014445:enzymes [Functional Concept]
   753   C1883712:Addition [Functional Concept]
   753   C2986669:Clarified [Activity]
Processing 00000000.tx.182: Molecular size markers are indicated at the left in kDa. 

Phrase: "Molecular size markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0596969:molecular size [Quantitative Concept]

Phrase: "are"

Phrase: "indicated at the left"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1444656:Indicated [Finding]
   770   C1552822:left [Functional Concept]

Phrase: "in kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.183: [View Larger Version of this Image (39K GIF file)] Sonication or boiling of the samples in SDS and 6M urea (data not shown) or extraction of the cells in the presence of 5 mM dithiothreitol did not resolve the aggregates (Fig. 6). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(39K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037680:Sonication [Research Activity]

Phrase: "or"

Phrase: "boiling of the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]

Phrase: "in SDS"

Phrase: "and"

Phrase: "6M urea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   805 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "extraction of the cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0684295:extraction [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5 mM dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "resolve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699488:Resolve [Conceptual Entity]

Phrase: "the aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.184: Denaturation of the immunoprecipitates at 37C instead of at 95C reduced the aggregates considerably but not completely (Fig. 6, lane 2). 

Phrase: "Denaturation of the immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0301642:Denaturation [Molecular Function]

Phrase: "at 37C"

Phrase: "instead of"

Phrase: "at 95C"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the aggregates considerably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "but"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.185: This demonstrated that the aggregates consisted mainly, if not exclusively, of PS1 as the radiolabeled species (Fig. 6) and also suggested that the PS aggregates are at least partially produced during the processing of the samples for electrophoresis. 

Phrase: "This"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "consisted"

Phrase: "mainly,"

Phrase: "if"

Phrase: "not exclusively,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "as the radiolabeled species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "also"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the PS aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "are at least partially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1551058:Are [Quantitative Concept]

Phrase: "produced during the processing of the samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1709694:Processing [Activity]
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "for electrophoresis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]
Processing 00000000.tx.186: It should be noticed, however, that even when freshly prepared material was used and heating of the samples was avoided, protein smears in the 100-250-kDa region remained visible in SDS-PAGE (Fig. 6). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noticed"

Phrase: ","

Phrase: "however,"

Phrase: "that even"

Phrase: "when"

Phrase: "freshly prepared material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "heating of the samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018851:Heating [Environmental Effect of Humans]

Phrase: "was"

Phrase: "avoided"

Phrase: ","

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "smears in the 100-250-kDa region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C0444186:Smear [Diagnostic Procedure]
   748   C1532717:kDa [Quantitative Concept]
   748   C1947932:Smear [Activity]

Phrase: "remained"

Phrase: "visible in SDS-PAGE (Fig. 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205379:Visible [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.187: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.188: 6. 

Phrase: "6."
Processing 00000000.tx.189: The presenilin aggregates are temperature-sensitive. 

Phrase: "The presenilin aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "are"

Phrase: "temperature-sensitive."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.190: Immunoprecipitated PS1 (antiserum B16) from transfected COS cells was denatured for 10min with SDS and -mercapthoethanol at 95C (lanes 1and 3) or at 37C (lane 2). 

Phrase: "Immunoprecipitated PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "(antiserum B16"

Phrase: ")"

Phrase: "from transfected COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "denatured for 10min"

Phrase: "with SDS"

Phrase: "and -"

Phrase: "mercapthoethanol at 95C"

Phrase: "(lanes 1and 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or at 37C"

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.191: In lane 3cell extracts were prepared in the presence of 5mM dithiothreitol (DTT). 

Phrase: "In lane 3cell extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared in the presence of 5mM dithiothreitol (DTT)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   714   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.192: Notice the decrease of the 100-250-kDa aggregates and the slightly increased intensity of the 45-kDa band in lane 2as compared to lanes 1 and 3. 

Phrase: "Notice"

Phrase: "the decrease of the 100-250-kDa aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "the slightly increased intensity of the 45-kDa band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0522510:Intensity [Qualitative Concept]

Phrase: "in lane 2as"

Phrase: "compared to lanes 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1707455:Compared [Activity]
   737   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.193: Samples were resolved on a 4-20% SDS-PAGE. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "resolved on a 4-20% SDS-PAGE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   774   C1538569:PAGE-4 [Gene or Genome]
   748   C1514893:Resolved [Idea or Concept]
   748   C1704732:Page [Intellectual Product]
   748   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.194: [View Larger Version of this Image (28K GIF file)] Phosphorylation of the Presenilins The high level of serines, threonines, and tyrosines in the primary amino acid sequences of both PS1 and PS2 suggested the possibility that the PS proteins are phosphoproteins (12, 13). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(28K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Phosphorylation of the Presenilins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "The high level of serines,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "threonines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "tyrosines in the primary amino acid sequences of both PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "PS2"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the PS proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "phosphoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031689:Phosphoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.195: Transfected COS-1 cells (Fig. 7) and CHO cells (Fig. 8B) incorporated 32P in presenilins. 

Phrase: "Transfected COS-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C1257857:COS-1 Cells [Cell]
   875   C0376702:COS Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")"

Phrase: "incorporated 32P in presenilins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1553631:32p [Medical Device]
Processing 00000000.tx.196: Acid hydrolysis of immunoprecipitated 32P-phosphorylated PS1 and PS2 yielded mainly phosphoserine (Fig. 7B). 

Phrase: "Acid hydrolysis of immunoprecipitated 32P-phosphorylated PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "PS2"

Phrase: "yielded"

Phrase: "mainly phosphoserine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031721:Phosphoserine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.197: Longer exposures revealed very weak signals for phosphothreonine, while phosphotyrosine was never observed. 

Phrase: "Longer exposures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0274281:exposures [Injury or Poisoning]
   861   C0728853:exposures [Phenomenon or Process]
   827 E C0332157:Exposure [Clinical Attribute]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "very weak signals for phosphothreonine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "while"

Phrase: "phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.198: The phosphorylation of PS1 was strongly increased, and that of PS2 slightly or not increased, by treating the cells with the phosphatase inhibitor okadaic acid (300nM, Fig. 8A). 

Phrase: "The phosphorylation of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "strongly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "that of PS2 slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750482:Slightly [Idea or Concept]

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "by treating"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treating [Therapeutic or Preventive Procedure]
  1000   C1522326:Treating [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "the cells with the phosphatase inhibitor okadaic acid"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   754   C0007634:THE CELL [Cell]
           Cells
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(300nM,"

Phrase: "Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.199: Okadaic acid inhibits the two major classes of serine/threonine phosphatases (49). 

Phrase: "Okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the two major classes of serine/threonine phosphatases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0456387:Class [Intellectual Product]
   744   C1705943:Class [Classification]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.200: The protein kinase C inhibitor staurosporin (300nM) or the agonists phorbol myristic acid (1M) and phorbol dibutyric acid (1M) and the protein kinase A agonist forskolin (100M) had no effect on the phosphorylation extent or pattern (Fig. 8A). 

Phrase: "The protein kinase C inhibitor staurosporin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   722   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   722   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(300nM"

Phrase: ")"

Phrase: "or"

Phrase: "the agonists phorbol myristic acid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0767601:phorbol myristic acid [Biologically Active Substance,Organic Chemical]
   861   C0027138:Myristic Acid [Biologically Active Substance,Lipid]
   812   C0001128:Acid [Chemical]
   812   C0031588:phorbol [Organic Chemical]
   812   C0070750:Phorbol [Organic Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "phorbol dibutyric acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the protein kinase A agonist forskolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   717   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(100M"

Phrase: ")"

Phrase: "had"

Phrase: "no effect on the phosphorylation extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.201: Attempts to phosphorylate immunoprecipitated PS1 in vitro using protein kinase A or protein kinase C remained also negative (results not shown). 

Phrase: "Attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "immunoprecipitated PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "protein kinase A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "remained"

Phrase: "also negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.202: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.203: 7. 

Phrase: "7."
Processing 00000000.tx.204: Phosphorylation of PS1 and PS2 on serine residues. 

Phrase: "Phosphorylation of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "PS2 on serine residues."
Processing 00000000.tx.205: Panel a, transfected COS-1 cells were metabolically labeled using [32P]orthophosphate and post-nuclear cell extracts were prepared (see "Materials and Methods"). 

Phrase: "Panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a,"

Phrase: "transfected COS-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C1257857:COS-1 Cells [Cell]
   875   C0376702:COS Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "metabolically"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "and"

Phrase: "post-nuclear cell extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007592:Cell Extracts [Cell Component]
   858   C1518434:Nuclear Extract [Biomedical or Dental Material]
   779   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "(see ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.206: PS1 and PS2 were immunoprecipitated with antiserum B16 (PS1) or 519(PS2). 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "were"

Phrase: "immunoprecipitated with antiserum B16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "519"

Phrase: "(PS2"

Phrase: ")."
Processing 00000000.tx.207: COS-1 cells transfected with pSG5 were labeled, extracted, and immunoprecipitated with the same antibodies (). 

Phrase: "COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with pSG5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1418997:PSG5 [Gene or Genome]

Phrase: "were"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: ","

Phrase: "and"

Phrase: "immunoprecipitated with the same antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0445247:Same [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.208: Panel b, thin layer chromatography of hydrolyzed PS1 (45kDa) and PS2 (50kDa) identifying serine as the phosphorylated residues. 

Phrase: "Panel b,"

Phrase: "thin layer chromatography of hydrolyzed PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0205168:Thin [Qualitative Concept]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]

Phrase: "(45kDa"

Phrase: ")"

Phrase: "and"

Phrase: "PS2"

Phrase: "(50kDa"

Phrase: ")"

Phrase: "identifying serine as the phosphorylated residues."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.209: The mobility of phosphoserine (S), phosphothreonine (T), or phosphotyrosine (Y), as detected by ninhydrin staining, is indicated by the dotted lines. 

Phrase: "The mobility of phosphoserine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0425245:Mobility [Finding]
   770   C0449580:Mobility [Qualitative Concept]

Phrase: "("

Phrase: "S)"

Phrase: ","

Phrase: "phosphothreonine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031724:Phosphothreonine [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Y"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "detected by ninhydrin staining,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0028098:Ninhydrin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   770   C0442726:Detected [Finding]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "indicated by the dotted lines."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205132:lines [Spatial Concept]
   760   C1444656:Indicated [Finding]
   726   C0872145:DOT [Therapeutic or Preventive Procedure]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.210: [View Larger Version of this Image (31K GIF file)] Fig. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(31K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.211: 8. 

Phrase: "8."
Processing 00000000.tx.212: Analysis of PS1 and PS2 phosphorylation. 

Phrase: "Analysis of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "PS2 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.213: Panel A, staurosporin (300nM) or okadaic acid (300nM) were added to the medium of transfected COS cells after a 3.5-h incubation with [32P]orthophosphate. 

Phrase: "Panel A,"

Phrase: "staurosporin"

Phrase: "(300nM"

Phrase: ")"

Phrase: "or"

Phrase: "okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(300nM"

Phrase: ")"

Phrase: "were"

Phrase: "added to the medium of transfected COS cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   770   C0376702:COS Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0009458:Medium [Intellectual Product]
   744   C0439536:Medium [Quantitative Concept]
   744   C0454802:Cos [Geographic Area]
   744   C1524062:Added [Functional Concept]
   744   C1705217:Medium [Substance]
   744   C3244283:medium [Intellectual Product]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1883712:Add [Functional Concept]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "after a 3.5-h incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0041119:3 H [Element, Ion, or Isotope]

Phrase: "with"

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]
Processing 00000000.tx.214: 30min later, cell extracts were made as in Fig. 

Phrase: "30min later,"

Phrase: "cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.215: 4. 

Phrase: "4."
Processing 00000000.tx.216: PS1 or PS2 were immunoprecipitated using, respectively, antiserum B17 or 519and resolved by a 4-20% gradient gel. 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "PS2"

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "respectively,"

Phrase: "antiserum B17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414132:B17 [Gene or Genome]
   861   C1417638:B17 [Gene or Genome]

Phrase: "or"

Phrase: "519and"

Phrase: "resolved by a 4-20% gradient gel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.217: Panel B, transfected CHO cells were labeled with [32P]orthophosphate and PS was immunoprecipitated using antiserum 519(PS2 WT) or B16 (all other lanes) and resolved by a 4-20% gradient gel. 

Phrase: "Panel B,"

Phrase: "transfected CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "and"

Phrase: "PS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418867:Ps [Gene or Genome]
  1000   C1518860:PS [Geographic Area]
  1000   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antiserum 519"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(PS2"

Phrase: "WT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "or"

Phrase: "B16"

Phrase: "("

Phrase: "all other lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "resolved by a 4-20% gradient gel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.218: [View Larger Version of this Image (30K GIF file)] Cytoplasmic Orientation of the Amino-terminal Domain and Hydrophilic Loop Domain of Presenilin 1 We finally addressed the issue whether the two major hydrophilic domains in presenilin 1,i.e. the amino-terminal domain and the hydrophilic loop domain (12) are oriented toward the cytoplasmic or the luminal side of the endoplasmic reticulum. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(30K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Cytoplasmic Orientation of the Amino-terminal Domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0029266:Orientation [Mental Process]
   748   C1704322:orientation [Spatial Concept]
   748   C1704972:Orientation [Spatial Concept]
   748   C3539923:Orientation [Intellectual Product]

Phrase: "and"

Phrase: "Hydrophilic Loop Domain of Presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "We finally"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "whether"

Phrase: "the two major hydrophilic domains in presenilin 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the amino-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the hydrophilic loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(12"

Phrase: ")"

Phrase: "are"

Phrase: "oriented toward the cytoplasmic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010834:Cytoplasmic [Cell Component]
   770   C0521449:Cytoplasmic [Body Location or Region]
   770   C1704322:Oriented [Spatial Concept]

Phrase: "or"

Phrase: "the luminal side of the endoplasmic reticulum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0441987:Side [Spatial Concept]
Processing 00000000.tx.219: Current models for the orientation of the presenilins in membranes are based on theoretical predictions (see "Discussion"). 

Phrase: "Current models for the orientation of the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Models [Intellectual Product]

Phrase: "in membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "are"

Phrase: "based on theoretical predictions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0681842:predictions [Idea or Concept]
   770   C0871935:Theoretical [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(see ""Discussion"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: ")."
Processing 00000000.tx.220: Both domains are candidate regions for interactions with other proteins, and their orientation determines whether this interaction occurs with cytoplasmic or endoplasmic reticulum proteins. 

Phrase: "Both domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1880389:Domain [Functional Concept]
   966   C1883221:Domain [Conceptual Entity]
   966   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "candidate regions for interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "with other proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "their orientation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0029266:Orientation [Mental Process]
  1000   C1704322:orientation [Spatial Concept]
  1000   C1704972:Orientation [Spatial Concept]
  1000   C3539923:Orientation [Intellectual Product]

Phrase: "determines"

Phrase: "whether"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "occurs with cytoplasmic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0010834:Cytoplasmic [Cell Component]
   790   C0521449:Cytoplasmic [Body Location or Region]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "or"

Phrase: "endoplasmic reticulum proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0014239:Endoplasmic Reticulum [Cell Component]
Processing 00000000.tx.221: To analyze this question, we used low concentrations of digitonin to selectively permeabilize the plasma membrane (see "Materials and Methods") and antibodies against the amino-terminal domain (antiserum B14), against the Myc tag introduced at the amino terminus (mAb 9E10), against the second loop domain (antibody 519), and, finally, against the hydrophilic loop domain (antiserum B16) of PS1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "this question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "low concentrations of digitonin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "to selectively"

Phrase: "permeabilize"

Phrase: "the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(see ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "antibodies against the amino-terminal domain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(antiserum B14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417627:B14 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "against the Myc tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "introduced at the amino terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1292748:introduce [Functional Concept]

Phrase: "(mAb 9E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "against the second loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(antibody 519"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: ","

Phrase: "finally,"

Phrase: "against the hydrophilic loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(antiserum B16"

Phrase: ")"

Phrase: "of PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.222: To monitor the permeabilization procedure, rat monoclonal antibody against the luminal endoplasmic reticulum retention signal KDEL was used (30, 31). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "the permeabilization procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "rat monoclonal antibody against the luminal endoplasmic reticulum retention signal KDEL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   738   C0746619:monoclonal [Finding]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.223: Antibodies against the amino-terminal domain of PS1, against the amino-terminally inserted Myc tag (Fig. 9a) or against the hydrophilic loop (Fig. 9e) reacted with PS1 in digitonin-permeabilized cells under conditions in which the KDEL-specific monoclonal antibody did not result in labeling (Fig. 9, a and e). 

Phrase: "Antibodies against the amino-terminal domain of PS1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against the amino-terminally inserted Myc tag (Fig. 9a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "or against the hydrophilic loop"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]
   760   C0475370:Hydrophilic [Qualitative Concept]

Phrase: "(Fig. 9e"

Phrase: ")"

Phrase: "reacted with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "in digitonin-permeabilized cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "in which"

Phrase: "the KDEL-specific monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in labeling"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1167624:Labeling [Mental Process]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C1947902:Labeling [Manufactured Object]
   790   C2825142:Result [Finding]
   790   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "(Fig. 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "e"

Phrase: ")."
Processing 00000000.tx.224: On the other hand, antibodies against the second hydrophilic loop domain (519) reacted with PS1 when saponin (Fig. 9d), but not when digitonin (Fig. 9c) was used to permeabilize the cells, suggesting a luminal localization of this domain. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "antibodies against the second hydrophilic loop domain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(519"

Phrase: ")"

Phrase: "reacted with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "when"

Phrase: "saponin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520481:Saponin [Steroid]
  1000   C0885750:saponin [Organic Chemical]

Phrase: "(Fig. 9d"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "when"

Phrase: "digitonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig. 9c"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "permeabilize"

Phrase: "the cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a luminal localization of this domain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]
Processing 00000000.tx.225: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.226: 9. 

Phrase: "9."
Processing 00000000.tx.227: Cytoplasmic orientation of the amino-terminal domain and the hydrophilic loop of PS1. 

Phrase: "Cytoplasmic orientation of the amino-terminal domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0029266:Orientation [Mental Process]
   748   C1704322:orientation [Spatial Concept]
   748   C1704972:Orientation [Spatial Concept]
   748   C3539923:Orientation [Intellectual Product]

Phrase: "and"

Phrase: "the hydrophilic loop of PS1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]
Processing 00000000.tx.228: COS-1 cells transfected with PS1Myc (panels a and b) or with PS1 WT (panels c-f) were permeabilized using digitonin (panels a, c, and e) or saponin (panels b, d, and f) and immunostained with anti-Myc mAb 9E10 (panels a and b), with polyclonal antibody 519against the second loop domain (panels c and d), with polyclonal antibody B16 (panels e and f) and with rat monoclonal antibody against the KDEL sequence (panels a-f). 

Phrase: "COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with PS1Myc"

Phrase: "(panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: "and"

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or with PS1 WT (panels c-f)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439133:(f) [Intellectual Product]
   748   C0441833:Panel [Idea or Concept]
   748   C1418985:PS1 [Gene or Genome]
   748   C1553038:[f] [Quantitative Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C2700323:WT [Fish]
   748   C2986918:PS1 [Gene or Genome]
   748   C3537156:Panel [Manufactured Object]

Phrase: "were"

Phrase: "permeabilized"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "digitonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a,"

Phrase: "c,"

Phrase: "and"

Phrase: "e)"

Phrase: "or"

Phrase: "saponin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520481:Saponin [Steroid]
  1000   C0885750:saponin [Organic Chemical]

Phrase: "(panels b,"

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "f)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "immunostained with anti-Myc mAb 9E10"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0746619:monoclonal [Finding]

Phrase: "(panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: "and"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "with polyclonal antibody 519against"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the second loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(panels c"

Phrase: "and"

Phrase: "d)"

Phrase: ","

Phrase: "with polyclonal antibody B16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(panels e"

Phrase: "and"

Phrase: "f)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and with rat monoclonal antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0746619:monoclonal [Finding]
   760   C1515981:And [Idea or Concept]

Phrase: "against the KDEL sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0166586:KDEL sequence [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "(panels a-f)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.229: PS1 immunoreactivity is observed as red/yellow staining, while KDEL immunoreactivity is green. 

Phrase: "PS1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "is"

Phrase: "observed as red/yellow staining,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0221205:Yellow [Qualitative Concept]
   760   C0332575:Red [Finding]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1260956:Red [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1704680:Staining [Finding]

Phrase: "while"

Phrase: "KDEL immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "is"

Phrase: "green."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.230: Panels a and b show that the amino terminus of PS1 is oriented to the cytoplasmic side of the endoplasmic reticulum membrane. 

Phrase: "Panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: "and"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the amino terminus of PS1"

Phrase: "is"

Phrase: "oriented to the cytoplasmic side of the endoplasmic reticulum membrane."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   795   C0230770:Membrane of endoplasmic reticulum [Cell Component]
           endoplasmic reticulum membrane
   760   C0014239:Endoplasmic Reticulum [Cell Component]
   757   C0007603:Cytoplasmic Membrane [Cell Component]
   739   C0010834:Cytoplasmic [Cell Component]
   739   C0025255:Membrane [Tissue]
   739   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   739   C0441987:Side [Spatial Concept]
   739   C0521449:Cytoplasmic [Body Location or Region]
   739   C0596901:Membrane [Cell Component]
   739   C1704322:Oriented [Spatial Concept]
   739   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.231: Cells that express PS1Myc stain strongly with the amino-terminal domain directed 9E10 mAb both in digitonin (a) or saponin (b) permeabilized cells. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "express"

Phrase: "PS1Myc"

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "strongly with the amino-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "directed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439851:Direct [Qualitative Concept]
   966   C1947931:Direct [Qualitative Concept]

Phrase: "9E10 mAb"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "both in digitonin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "(a)"

Phrase: "or"

Phrase: "saponin (b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520481:Saponin [Steroid]
   861   C0885750:saponin [Organic Chemical]

Phrase: ")"

Phrase: "permeabilized cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.232: When saponin is used, the untransfected cells are stained with the KDEL antibody (green) since it reacts with endogenous proteins (b). 

Phrase: "When"

Phrase: "saponin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520481:Saponin [Steroid]
  1000   C0885750:saponin [Organic Chemical]

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "the untransfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "stained with the KDEL antibody"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "since"

Phrase: "it"

Phrase: "reacts with endogenous proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205227:Endogenous [Functional Concept]

Phrase: "(b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.233: When digitonin is used, no staining is observed (a), indicating that the endoplasmic reticulum membrane is not permeable for antibodies under the conditions used. 

Phrase: "When"

Phrase: "digitonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "no staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "("

Phrase: "a"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the endoplasmic reticulum membrane"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0230770:endoplasmic reticulum membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "is"

Phrase: "not permeable for antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205326:Permeable [Functional Concept]

Phrase: "under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.234: In panels c and d, similar experiments are displayed but using antiserum 519against the second loop domain. 

Phrase: "In panels c"

Phrase: "and"

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "similar experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "but"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antiserum 519against"

Phrase: "the second loop domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.235: Staining is only observed when saponin is used, indicating a luminal orientation of this domain (panel d). 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "saponin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520481:Saponin [Steroid]
  1000   C0885750:saponin [Organic Chemical]

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "indicating"

Phrase: "a luminal orientation of this domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0029266:Orientation [Mental Process]
   753   C1704322:orientation [Spatial Concept]
   753   C1704972:Orientation [Spatial Concept]
   753   C3539923:Orientation [Intellectual Product]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "d)."
Processing 00000000.tx.236: Panels e and f demonstrate that antiserum B16 against the hydrophilic loop domain of PS1 react both with digitonin (e) or saponin (f) permeabilized cells, indicating a cytoplasmic orientation of the hydrophilic loop. 

Phrase: "Panels e"

Phrase: "and"

Phrase: "f"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "demonstrate"

Phrase: "that antiserum B16 against the hydrophilic loop domain of PS1"

Phrase: "react"

Phrase: "both with digitonin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "(e)"

Phrase: "or"

Phrase: "saponin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520481:Saponin [Steroid]
  1000   C0885750:saponin [Organic Chemical]

Phrase: "(f) permeabilized cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "indicating"

Phrase: "a cytoplasmic orientation of the hydrophilic loop."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0029266:Orientation [Mental Process]
   748   C1704322:orientation [Spatial Concept]
   748   C1704972:Orientation [Spatial Concept]
   748   C3539923:Orientation [Intellectual Product]
Processing 00000000.tx.237: [View Larger Version of this Image (91K GIF file)] DISCUSSION The current investigation provides a detailed characterization of the biosynthesis of presenilins overexpressed in COS-1 cells and CHO cells. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(91K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "The current investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a detailed characterization of the biosynthesis of presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "overexpressed in COS-1 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C1257857:COS-1 Cells [Cell]
   806   C0376702:COS-1 [Cell]
           COS Cells
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1514559:overexpress [Genetic Function]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.238: The results show that the PS proteins are unglycosylated phosphoproteins with apparent molecular masses of about 45and 50kDa in SDS-PAGE. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the PS proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "unglycosylated phosphoproteins with apparent molecular masses of about 45and 50kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0031689:Phosphoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in SDS-PAGE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]
Processing 00000000.tx.239: They have a strong tendency to form SDS-resistant complexes with apparent molecular masses between 100and 250kDa. 

Phrase: "They"

Phrase: "have"

Phrase: "a strong tendency to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "SDS-resistant complexes with apparent molecular masses"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1704241:Complexes [Chemical Viewed Structurally]
   714 E C0439855:Complex [Qualitative Concept]

Phrase: "between 100and 250kDa."
Processing 00000000.tx.240: Double immunofluorescence studies showed that PS1 is mainly located in the endoplasmic reticulum and the Golgi apparatus and that its amino-terminal domain and the hydrophilic loop domain are oriented to the cytoplasmic side. 

Phrase: "Double immunofluorescence studies"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   827   C0016318:Immunofluorescence [Laboratory Procedure]
   827   C0079603:Immunofluorescence [Laboratory Procedure]
   827   C0205173:Double [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1705764:Double [Activity]
   827   C1705765:Double [Qualitative Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   771 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   755 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "mainly"

Phrase: "located in the endoplasmic reticulum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the Golgi apparatus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]

Phrase: "and"

Phrase: "that"

Phrase: "its amino-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the hydrophilic loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "oriented to the cytoplasmic side."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0010834:Cytoplasmic [Cell Component]
   760   C0441987:Side [Spatial Concept]
   760   C0521449:Cytoplasmic [Body Location or Region]
   760   C1704322:Oriented [Spatial Concept]
Processing 00000000.tx.241: The localization of transfected PS1 in the endoplasmic reticulum of COS-1 cells or CHO cells is not a simple consequence of overexpression of the protein or nonspecific general effects on the biosynthetic pathway in these cells. 

Phrase: "The localization of transfected PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "in the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "of COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a simple consequence of overexpression of the protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "or"

Phrase: "nonspecific general effects on the biosynthetic pathway"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "in these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.242: First, endogeneous presenilins are located in the endoplasmic reticulum of untransfected cells as demonstrated in Fig. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "endogeneous presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "located in the endoplasmic reticulum of untransfected cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0014239:Endoplasmic Reticulum [Cell Component]
   750   C0229606:Reticulum cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "demonstrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.243: 1A using confocal laser microscopy. 

Phrase: "1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "confocal laser microscopy."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0242842:Microscopy, Confocal [Laboratory Procedure]
   901   C0600395:Laser Microscopy [Laboratory Procedure]
   827   C0026018:Microscopy [Laboratory Procedure]
   755 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.244: Second, using identical transfection conditions, APP and furin were found to accumulate in the Golgi apparatus, as demonstrated before (33, 34). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "identical transfection conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accumulate in the Golgi apparatus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   760   C0243111:apparatus [Manufactured Object]
   760   C1947951:Apparatus [Anatomical Structure]

Phrase: "as"

Phrase: "demonstrated"

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "(33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.245: Third, the turnover (Fig. 4) and the secretory processing of APP3 in CHO cells stably expressing human APP770 was not affected by transfection of PS1, ruling out general inhibitory effects on protein transport and processing. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "the turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031227:turnover [Quantitative Concept]
  1000   C0243127:turnover [Functional Concept]
  1000   C0443331:Turnover [Health Care Activity]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "the secretory processing of APP3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709694:Processing [Activity]

Phrase: "in CHO cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human APP770"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by transfection of PS1,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1418985:PS1 [Gene or Genome]
   760   C2986918:PS1 [Gene or Genome]
   726 E C0001721:Affect [Mental Process]

Phrase: "ruling"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruling [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out general inhibitory effects on protein transport"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "processing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]
Processing 00000000.tx.246: On the other hand, the levels of endogeneous presenilin in COS-1 cells are apparently very low. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the levels of endogeneous presenilin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "apparently very low."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0442811:Very low [Finding]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
Processing 00000000.tx.247: Only the combination of immunoprecipitation to concentrate PS1 from detergent extracts of 10106 cells, followed by immunoblotting using mAb PS1-3, allowed us to detect endogeneous PS1 migrating at the same molecular weight as transfected PS1. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the combination of immunoprecipitation to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "concentrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1880310:Concentrate [Manufactured Object]
  1000   C2003864:Concentrate [Substance]

Phrase: "PS1 from detergent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "extracts of 10106 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0007592:Cell Extracts [Cell Component]
   770   C0007634:Cells [Cell]
   770   C2828366:Extract [Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mAb PS1-3,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0746619:monoclonal [Finding]
   812   C1418985:PS1 [Gene or Genome]
   812   C2986918:PS1 [Gene or Genome]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "endogeneous PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "migrating at the same molecular weight"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0026385:Molecular Weight [Quantitative Concept]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C0232902:migrating [Functional Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]

Phrase: "as transfected PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.248: The disadvantage of this approach is that the antibodies from the immunoprecipitation step interfere with the consecutive detection of possible PS-aggregates in the immunoblotting step (Fig. 3C). 

Phrase: "The disadvantage of this approach"

Phrase: "is"

Phrase: "that"

Phrase: "the antibodies from the immunoprecipitation step"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "interfere with the consecutive detection of possible PS-aggregates"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0205418:aggregates [Qualitative Concept]
   742   C0332149:Possible [Qualitative Concept]
   742   C0521102:Interfere [Qualitative Concept]
   742   C1418867:Ps [Gene or Genome]
   742   C1511790:Detection [Therapeutic or Preventive Procedure]
   742   C1518860:PS [Geographic Area]
   742   C1552158:Ps [Body Part, Organ, or Organ Component]
   742   C1705910:Possible [Qualitative Concept]
   742   C1707491:Consecutive [Qualitative Concept]
   742   C2362652:Possible [Qualitative Concept]

Phrase: "in the immunoblotting step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.249: This assay also precludes a dynamic analysis of the metabolism of the presenilins using metabolic labeling and pulse-chase experiments. 

Phrase: "This assay also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "precludes"

Phrase: "a dynamic analysis of the metabolism of the presenilins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "metabolic labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "pulse-chase experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.250: On the other hand, it allowed us to demonstrate the presence or absence of particular antibody epitopes on PS1 fragments. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "it"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of particular antibody epitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "on PS1 fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.251: Importantly, the use of hydrophilic loop-specific antibodies in the immunoprecipitation step resulted in the detection of relative large amounts of, presumably proteolytic, fragments of PS1 in the 18-30-kDa range (Fig. 3C). 

Phrase: "Importantly,"

Phrase: "the use of hydrophilic loop-specific antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "in the immunoprecipitation step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "resulted in the detection of relative large amounts of,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C0549177:Large [Quantitative Concept]
   742   C1265611:amounts [Quantitative Concept]
   742   C1511790:Detection [Therapeutic or Preventive Procedure]
   742   C1547039:*Relative [Quantitative Concept]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "presumably proteolytic,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597304:Proteolytic [Molecular Function]
   861   C1947941:proteolytic [Enzyme]

Phrase: "fragments of PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C1708096:Fragment [Qualitative Concept]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "in the 18-30-kDa range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514721:Range [Quantitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C3542016:Range [Intellectual Product]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.252: The level of these fragments was not, or only slightly, increased in COS-1 cells that overexpressed PS1, which explains why they were not readily detected in the transfection experiments. 

Phrase: "The level of these fragments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "or"

Phrase: "only slightly,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0750482:Slightly [Idea or Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "increased in COS-1 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C1257857:COS-1 Cells [Cell]
   806   C0376702:COS-1 [Cell]
           COS Cells
   760   C0007634:Cells [Cell]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "that overexpressed PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "which"

Phrase: "explains"

Phrase: "why"

Phrase: "they"

Phrase: "were"

Phrase: "not readily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "detected in the transfection experiments."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   760   C0442726:Detected [Finding]
   760   C0681814:Experiments [Research Activity]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.253: The proteolytic process involved is probably easily saturated or even inhibited by PS overexpression (35, 36). 

Phrase: "The proteolytic process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "is"

Phrase: "probably easily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332219:Easily [Qualitative Concept]
   861   C0750492:Probably [Idea or Concept]

Phrase: "saturated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522534:Saturated [Phenomenon or Process]
  1000   C1705188:SATURATED [Quantitative Concept]

Phrase: "or"

Phrase: "even"

Phrase: "inhibited by PS overexpression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0311403:Inhibited [Qualitative Concept]
   770   C1418867:Ps [Gene or Genome]
   770   C1514559:Overexpression [Genetic Function]
   770   C1518860:PS [Geographic Area]
   770   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.254: Our data therefore do not allow us to speculate any further on the exact nature or the biological significance of this process. 

Phrase: "Our data therefore"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "any further on the exact nature"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1517331:Further [Spatial Concept]
   719 E C0205108:far [Spatial Concept]

Phrase: "or"

Phrase: "the biological significance of this process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]
Processing 00000000.tx.255: We can only conclude that overexpression studies of the type used here are not suitable to study this particular aspect of presenilin metabolism. 

Phrase: "We"

Phrase: "can"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "studies of the type"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0035171:Study Type [Research Activity]
   819   C2985227:Study Type [Research Activity]
   770   C0332307:Type [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1547052:*Type [Quantitative Concept]
   770   C2603343:Study [Research Activity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "not suitable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "this particular aspect of presenilin metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1547011:Aspect [Quantitative Concept]
   753   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.256: On the other hand, it is clear that untransfected cells (Fig. 3) and brain tissue in vivo (36, 37) contain detectable amounts of intact presenilin. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that untransfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "brain tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0440746:Brain tissue [Tissue]
  1000   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(36,"

Phrase: "37"

Phrase: ")"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "detectable amounts of intact presenilin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]
Processing 00000000.tx.257: Since this endogeneously expressed PS1 has the same mobility as transfected PS1, the conclusion that transfected PS1 (and PS2) are not subject to glycosylation, sulfation, glycosaminoglycan modification, palmitoylation, or myristoylation also holds apparently true for the endogeneous protein. 

Phrase: "Since"

Phrase: "this endogeneously expressed PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "has"

Phrase: "the same mobility as transfected PS1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0425245:Mobility [Finding]
   753   C0449580:Mobility [Qualitative Concept]

Phrase: "the conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "that transfected PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "("

Phrase: "and"

Phrase: "PS2"

Phrase: ")"

Phrase: "are"

Phrase: "not subject to glycosylation,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0017982:glycosylation [Natural Phenomenon or Process]
   770   C0376322:Glycosylation [Molecular Function]
   770   C0681850:Subject [Group]
   770   C1518422:Not [Functional Concept]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "sulfation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597538:Sulfation [Phenomenon or Process]

Phrase: "glycosaminoglycan modification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "palmitoylation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598435:Palmitoylation [Molecular Function]

Phrase: "or"

Phrase: "myristoylation also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598434:myristoylation [Molecular Function]

Phrase: "holds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553387:Hold [Idea or Concept]
  1000   C1948035:Hold [Activity]

Phrase: "apparently true for the endogeneous protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205238:True [Qualitative Concept]
Processing 00000000.tx.258: These posttranslational modifications are thereby also excluded as contributing to the formation of the high molecular mass, SDS-resistant aggregates (100-250 kDa) in SDS-PAGE electrophoresis. 

Phrase: "These posttranslational modifications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033666:Post-Translational Modifications [Molecular Function]
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "are"

Phrase: "thereby also"

Phrase: "excluded as contributing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1554077:Excluded [Idea or Concept]
   790   C1880177:Contributing [Activity]
   790   C2828389:Excluded [Activity]
   756 E C0332196:Exclude [Functional Concept]

Phrase: "to the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of the high molecular mass,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "SDS-resistant aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "(100-250 kDa) in SDS-PAGE electrophoresis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.259: These aggregates were observed to a variable extent in all our experiments, and were noticed by others using other cell types or brain tissue (36, 38, 39). 

Phrase: "These aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "observed to a variable extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439792:Extent [Spatial Concept]
   760   C0439828:Variable [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "in all"

Phrase: "our experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "noticed by others"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1955473:Others [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "other cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "brain tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0440746:Brain tissue [Tissue]
  1000   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "(36,"

Phrase: "38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.260: Since the smears were detected with three different antibodies recognizing three different epitopes, and by a Myc-directed mAb using a Myc-tagged PS1 construct, the aggregates must contain presenilin core proteins, alone or associated with unidentified components. 

Phrase: "Since"

Phrase: "the smears"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444186:smears [Diagnostic Procedure]
   966 E C1947932:Smear [Activity]

Phrase: "were"

Phrase: "detected with three different antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205449:Three [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1705242:Different [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizing"

Phrase: "three different epitopes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitopes [Immunologic Factor]

Phrase: "and by a Myc-directed mAb"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0746619:monoclonal [Finding]
   748   C1515981:And [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Myc-tagged PS1 construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2827421:Construct [Classification]

Phrase: "the aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "must"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "presenilin core proteins,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0444669:Core [Spatial Concept]
   827   C1167518:core [Cell Component]
   827   C1706352:Core [Medical Device]
   827   C1882467:Core [Manufactured Object]
   827   C3274653:Core [Body Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "associated with unidentified components."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205427:Unidentified [Qualitative Concept]
   770   C0449432:Components [Manufactured Object]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1705248:Component [Conceptual Entity]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.261: Denaturation of immunoprecipitates at 37C instead of 95C, resulted in less aggregates and increased amounts of the 45-kDa PS1 band (Fig. 3C). 

Phrase: "Denaturation of immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0301642:Denaturation [Molecular Function]

Phrase: "at 37C"

Phrase: "instead of 95C,"

Phrase: "resulted in less"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "increased amounts of the 45-kDa PS1 band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:amounts [Quantitative Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.262: The aggregates therefore probably consist mainly of oligomers of presenilins. 

Phrase: "The aggregates therefore probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205418:aggregates [Qualitative Concept]
   827   C0750492:Probably [Idea or Concept]

Phrase: "consist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332529:CONSIST [Qualitative Concept]

Phrase: "mainly of oligomers of presenilins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.263: It is unclear whether this property to form SDS-resistant aggregates in vitro has any physiological significance in vivo, but immuno-electron microscope observations suggest that clustering of presenilins also occurs in the endoplasmic reticulum of untransfected cells.2 It should be envisaged that in pathological conditions exacerbated aggregation of presenilins could become a problem. 

Phrase: "It"

Phrase: "is"

Phrase: "unclear"

Phrase: "whether"

Phrase: "this property to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0871161:Property [Qualitative Concept]
   861   C1882134:Property [Conceptual Entity]
   861   C2347695:Property [Entity]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "SDS-resistant aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "has"

Phrase: "any physiological significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0237881:Significance [Quantitative Concept]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "but"

Phrase: "immuno-electron microscope observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0302523:observations [Research Activity]
   812   C0700325:observations [Health Care Activity]
   812   C3244290:observations [Functional Concept]
   779 E C1964257:Observation [Diagnostic Procedure]
   729 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that clustering of presenilins also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009085:Clustering [Research Activity]

Phrase: "occurs in the endoplasmic reticulum of untransfected cells.2"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C0014239:Endoplasmic Reticulum [Cell Component]
   745   C0229606:Reticulum cell [Cell]
   742   C0007634:Cells [Cell]
   742   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   742   C1709305:Occur [Activity]
   742   C2745955:OCCUR [Temporal Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "envisaged"

Phrase: "that in pathological conditions"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C1521733:Pathological [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "exacerbated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0436331:Exacerbated [Finding]
  1000   C1444749:Exacerbated [Qualitative Concept]

Phrase: "aggregation of presenilins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "could"

Phrase: "become"

Phrase: "a problem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033213:Problem [Finding]
Processing 00000000.tx.264: In this context, it should be mentioned that antibodies against PS1 stain amyloid plaques in the brains of Alzheimer's disease patients (40). 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "it"

Phrase: "should"

Phrase: "be"

Phrase: "mentioned"

Phrase: "that antibodies against PS1 stain amyloid plaques"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of Alzheimer's disease patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.265: Importantly, the two point mutations causing Alzheimer's disease that were studied here, i.e. 

Phrase: "Importantly,"

Phrase: "the two point mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "here,"

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.266: PS1 Ala-246 Glu (FAD1 kindred) and PS1 Cys-410 Tyr (NIH2 kindred), did not alter the biosynthesis or level of expression of the PS1 protein in COS-1 cells and CHO cells. 

Phrase: "PS1 Ala-246 Glu (FAD1 kindred"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0598429:kindred [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PS1 Cys-410 Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C1421250:TYR [Gene or Genome]

Phrase: "(NIH2 kindred"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598429:kindred [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005572:biosynthesis [Functional Concept]
  1000   C0220781:Biosynthesis [Biologic Function]

Phrase: "or"

Phrase: "level of expression of the PS1 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0428479:Protein level [Laboratory or Test Result]
   774   C3244092:expression level [Idea or Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.267: These mutations must cause therefore more subtle effects. 

Phrase: "These mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "must"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "therefore more subtle effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1280500:effects [Qualitative Concept]
   779 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.268: The possibility that they interfere with the fragmentation of PS1, as was shown recently for two other mutations (35, 36), cannot be excluded from the current data. 

Phrase: "The possibility"

Phrase: "that"

Phrase: "they"

Phrase: "interfere with the fragmentation of PS1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332472:Fragmentation [Anatomical Abnormality]
   753   C0521102:Interfere [Qualitative Concept]
   753   C1418985:PS1 [Gene or Genome]
   753   C1881708:FRAGMENTATION [Phenomenon or Process]
   753   C2986918:PS1 [Gene or Genome]

Phrase: "as"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "recently for two"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205448:Two [Quantitative Concept]
   790   C0332185:Recently [Temporal Concept]

Phrase: "other mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(35,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded from the current data."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0521116:Current [Temporal Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1554077:Excluded [Idea or Concept]
   760   C1705970:Current [Natural Phenomenon or Process]
   760   C2828389:Excluded [Activity]
   760   C3245479:data [Medical Device]
   726 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.269: Analysis of brains of transgenic mice expressing the PS1 Ala-246 Glu mutant indicate, however, that at least this mutation does not interfere with the proteolytic processing of PS1.4 Since all PS mutations known to date act in a dominant way in the pathogenesis of Alzheimer's disease, a gain of function is most likely. 

Phrase: "Analysis of brains of transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "expressing"

Phrase: "the PS1 Ala-246 Glu mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "indicate"

Phrase: ","

Phrase: "however,"

Phrase: "that at least"

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with the proteolytic processing of PS1.4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1514570:Proteolytic Processing [Molecular Function]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0521102:Interfere [Qualitative Concept]
   744   C0597304:Proteolytic [Molecular Function]
   744   C1418985:PS1 [Gene or Genome]
   744   C1709694:Processing [Activity]
   744   C1947941:proteolytic [Enzyme]
   744   C2986918:PS1 [Gene or Genome]

Phrase: "Since"

Phrase: "all PS mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "known to date"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011008:Date [Temporal Concept]
   790   C0205309:Known [Qualitative Concept]
   790   C2348077:Date [Food]

Phrase: "act in a dominant way"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C1527180:Dominant [Functional Concept]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "a gain of function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517378:Gain [Quantitative Concept]

Phrase: "is"

Phrase: "most likely."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]
Processing 00000000.tx.270: Evidence that fibroblasts derived from patients with presenilin mutations produce more and longer forms of the A4 amyloid peptide suggests that the mutations exert their effect on cellular metabolism or trafficking of amyloid precursor protein (21). 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "derived from patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "with presenilin mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "produce"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "and"

Phrase: "longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]

Phrase: "forms of the A4 amyloid peptide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1522492:Form [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "their effect on cellular metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "trafficking of amyloid precursor protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0599895:Protein Trafficking [Cell Function]
   797   C1159772:Protein Trafficking [Cell Function]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0599896:trafficking [Cell Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.271: The localization of PS1 in the early compartments of the biosynthetic pathway makes it unlikely that the presenilin mutations directly influence - and/or -secretase activity, since these operate in the late-Golgi and transport vesicles, at the cell surface and in endosomes (27, 41-43). 

Phrase: "The localization of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "in the early compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "of the biosynthetic pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1721101:Pathway, Biosynthetic [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the presenilin mutations directly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "influence"

Phrase: "-"

Phrase: "and/or -"

Phrase: "secretase activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "since"

Phrase: "these"

Phrase: "operate in the late-Golgi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2611787:late Golgi [Cell Component]
   760   C0018042:Golgi [Cell Component]
   760   C0205087:Late [Temporal Concept]
   760   C3242339:operate [Functional Concept]

Phrase: "and"

Phrase: "transport vesicles,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0887882:Transport Vesicles [Cell Component]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0333262:VESICLES [Acquired Abnormality]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "at the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "and in endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034850:Endosomes [Cell Component]
   790   C1515981:And [Idea or Concept]

Phrase: "(27,"

Phrase: "41-43"

Phrase: ")."
Processing 00000000.tx.272: The possibility that PS mutants influence the balance between amyloidogenic and non-amyloidogenic processing of APP in an indirect way by changing its intracellular trafficking should now be further explored in polarized Madin-Darby canine kidney cells and neurons (16, 44, 45). 

Phrase: "The possibility"

Phrase: "that PS mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "influence"

Phrase: "the balance between amyloidogenic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014653:Balance [Organism Function]
   770   C0205415:Balance [Functional Concept]
   770   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "non-amyloidogenic processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0033666:protein processing [Molecular Function]
   748   C1709694:Processing [Activity]

Phrase: "in an indirect way"

Phrase: "by changing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changing [Functional Concept]
  1000   C0443172:changing [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "its intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "should"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "explored in polarized Madin-Darby canine kidney cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   869   C0598829:Madin Darby Canine Kidney Cells [Cell]
   767   C0553257:cells kidney [Cell]
   750   C0598102:polarized cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0012984:Canine, NOS [Mammal]
   744   C0022646:Kidney [Body Part, Organ, or Organ Component]
   744   C0227665:kidney [Body Part, Organ, or Organ Component]
   744   C1278978:Kidney [Body Part, Organ, or Organ Component]
   744   C1280551:Canine [Mammal]
   744   C1514845:KIDNEY [Tissue]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(16,"

Phrase: "44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.273: Our study demonstrates furthermore that the presenilins are phosphorylated on serine residues. 

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrates"

Phrase: "furthermore"

Phrase: "that"

Phrase: "the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "phosphorylated on serine residues."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.274: Phosphorylation of PS1 and PS2 was evident both in COS-1 cells and CHO cells, but the phosphorylation of PS1 was less intense and more variable than of PS2. 

Phrase: "Phosphorylation of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "PS2"

Phrase: "was"

Phrase: "evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "both in COS-1 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C1257857:COS-1 Cells [Cell]
   806   C0376702:COS-1 [Cell]
           COS Cells
   760   C0007634:Cells [Cell]
   760   C0238767:Both [Spatial Concept]
   760   C0454802:Cos [Geographic Area]
   760   C1706086:Both [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "CHO cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "the phosphorylation of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "less intense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intense [Qualitative Concept]

Phrase: "and"

Phrase: "more variable than of PS2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439828:Variable [Qualitative Concept]
Processing 00000000.tx.275: The observation that okadaic acid enhanced the PS1 phosphorylation suggests that PS1 is more prone to phosphatase activity than PS2 (Fig. 8A). 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the PS1 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "more prone to phosphatase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033422:Prone [Spatial Concept]

Phrase: "than PS2"

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.276: Protein kinase C is not responsible for PS phosphorylation, since neither stimulation of cells by phorbol esters nor purified kinase added to immunoprecipitated PS1 or PS2 resulted in increased labeling. 

Phrase: "Protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not responsible for PS phosphorylation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "since"

Phrase: "neither stimulation of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by phorbol esters"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031586:Phorbol Esters [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0014898:Esters [Organic Chemical]
   861   C0031588:phorbol [Organic Chemical]
   861   C0070750:Phorbol [Organic Chemical]

Phrase: "nor"

Phrase: "purified kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "added to immunoprecipitated PS1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PS1 [Gene or Genome]
   770   C1524062:Added [Functional Concept]
   770   C2986918:PS1 [Gene or Genome]
   737   C0301871:Immunoprecipitate [Immunologic Factor]
   737 E C1883712:Add [Functional Concept]

Phrase: "or"

Phrase: "PS2"

Phrase: "resulted in increased labeling."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]
Processing 00000000.tx.277: It is therefore unlikely that the presenilins are directly involved in the regulation of APP secretion by protein kinase C (46, 47). 

Phrase: "It"

Phrase: "is"

Phrase: "therefore unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "involved in the regulation of APP secretion"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   807   C1327618:regulation of protein secretion [Cell Function]
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   784   C1523071:regulation of secretion [Cell Function]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159339:Protein Secretion [Cell Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1314939:Involved [Functional Concept]
   742   C1327622:Regulation [Biologic Function]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "by protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(46,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.278: Finally, we showed that the hydrophilic NH2-terminal and the major loop domain of PS1 are exposed to the cytoplasmic side of the endoplasmic reticulum membrane. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the hydrophilic NH2-terminal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002508:NH2 [Organic Chemical]
   827   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "the major loop domain of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "exposed to the cytoplasmic side of the endoplasmic reticulum membrane."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   795   C0230770:Membrane of endoplasmic reticulum [Cell Component]
           endoplasmic reticulum membrane
   760   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0332157:Exposed to [Clinical Attribute]
           Exposed
   757   C0007603:Cytoplasmic Membrane [Cell Component]
   739   C0010834:Cytoplasmic [Cell Component]
   739   C0025255:Membrane [Tissue]
   739   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   739   C0441987:Side [Spatial Concept]
   739   C0521449:Cytoplasmic [Body Location or Region]
   739   C0596901:Membrane [Cell Component]
   739   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.279: Digitonin at low concentrations selectively permeabilizes the cell membrane, but not the endoplasmic reticulum membrane (29). 

Phrase: "Digitonin at low concentrations selectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "permeabilizes"

Phrase: "the cell membrane,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0007603:Cell Membrane [Cell Component]
  1000   C3161472:Cell Membrane [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1706182:Membrane [Manufactured Object]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the endoplasmic reticulum membrane"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0230770:endoplasmic reticulum membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.280: Antibodies directed toward the amino-terminal domain of PS1 (Fig. 9) displayed similar immunofluorescent staining patterns in digitonin and saponin permeabilized cells. 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed toward the amino-terminal domain of PS1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0205088:Terminal [Temporal Concept]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1418985:PS1 [Gene or Genome]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C2986918:PS1 [Gene or Genome]
   744   C3541951:Domain [Intellectual Product]
   711   C0439851:Direct [Qualitative Concept]
   711   C1947931:Direct [Qualitative Concept]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "similar immunofluorescent staining patterns in digitonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0449778:patterns staining [Spatial Concept]
   753   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "saponin permeabilized cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.281: Control experiments with antibodies against a luminal epitope, i.e. the KDEL endoplasmic reticulum retention signal (30, 31), showed that digitonin did not permeabilize the endoplasmic reticulum membrane. 

Phrase: "Control experiments with antibodies"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0009932:control experiments [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "against a luminal epitope,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the KDEL endoplasmic reticulum retention signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that digitonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "permeabilize"

Phrase: "the endoplasmic reticulum membrane."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0230770:endoplasmic reticulum membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]
Processing 00000000.tx.282: For the major hydrophilic loop domain, essentially identical results were obtained. 

Phrase: "For the major hydrophilic loop domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "essentially identical results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.283: The conclusion therefore is that the two major hydrophilic domains in PS1 are oriented to the cytoplasmic side of the endoplasmic reticulum, which directs the search for candidate proteins interacting with these domains toward the cytoplasm. 

Phrase: "The conclusion therefore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the two major hydrophilic domains in PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1880389:Domain [Functional Concept]
   714   C1883221:Domain [Conceptual Entity]
   714   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "oriented to the cytoplasmic side of the endoplasmic reticulum,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0014239:Endoplasmic Reticulum [Cell Component]
   742   C0010834:Cytoplasmic [Cell Component]
   742   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   742   C0441987:Side [Spatial Concept]
   742   C0521449:Cytoplasmic [Body Location or Region]
   742   C1704322:Oriented [Spatial Concept]

Phrase: "which"

Phrase: "directs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "the search for candidate proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552603:search [Intellectual Product]
   760   C1706202:Search [Activity]

Phrase: "interacting with these domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "toward the cytoplasm."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.284: Consistent with this conclusion, antibodies against the second loop domain reacted with PS1 after saponin, but not after digitonin permeabilization. 

Phrase: "Consistent with this conclusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "antibodies against the second loop domain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "reacted with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "after saponin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520481:Saponin [Steroid]
  1000   C0885750:saponin [Organic Chemical]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "after"

Phrase: "digitonin permeabilization."
Processing 00000000.tx.285: This not only confirms the luminal localization of the recognized epitope, but also validates the approach as it was used. 

Phrase: "This"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the luminal localization of the recognized epitope,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "but"

Phrase: "also"

Phrase: "validates"

Phrase: "the approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "as"

Phrase: "it"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.286: While more detailed studies, including electron microscopy and enzymatic digestion protection assays, are required to settle definitively the orientation of the presenilins in the endoplasmic reticulum membrane, our results clarify already two important issues. 

Phrase: "While"

Phrase: "more detailed studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "electron microscopy"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: "and"

Phrase: "enzymatic digestion protection assays,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C2717977:Enzymatic Assays [Laboratory Procedure]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "are"

Phrase: "required to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1514873:Required [Functional Concept]

Phrase: "settle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1266099:SETTLE [Neoplastic Process]

Phrase: "definitively"

Phrase: "the orientation of the presenilins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0029266:Orientation [Mental Process]
   760   C1704322:orientation [Spatial Concept]
   760   C1704972:Orientation [Spatial Concept]
   760   C3539923:Orientation [Intellectual Product]

Phrase: "in the endoplasmic reticulum membrane,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0230770:endoplasmic reticulum membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "already two important issues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0033213:Issue [Finding]
   779   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.287: The first problem is the orientation of the first transmembrane domain in PS1, which determines in fact the topology of all the following transmembrane domains (46). 

Phrase: "The first problem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033213:Problem [Finding]

Phrase: "is"

Phrase: "the orientation of the first transmembrane domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0029266:Orientation [Mental Process]
   748   C1704322:orientation [Spatial Concept]
   748   C1704972:Orientation [Spatial Concept]
   748   C3539923:Orientation [Intellectual Product]

Phrase: "in PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "which"

Phrase: "determines in fact"

Phrase: "the topology of all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002812:Topology [Biomedical Occupation or Discipline]

Phrase: "the following transmembrane domains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C1519623:Transmembrane Domain [Amino Acid Sequence]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.288: The positive charge difference between the 15carboxyl-terminal and the 15amino-terminal residues flanking the first membrane spanning domain suggests a luminal orientation of its amino terminus (48). 

Phrase: "The positive charge difference between the 15carboxyl-terminal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "the 15amino-terminal residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the first membrane spanning domain"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   812   C0025255:Membrane [Tissue]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]
   779   C1711300:Span [Conceptual Entity]
   779   C2700613:Span [Quantitative Concept]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a luminal orientation of its amino terminus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0029266:Orientation [Mental Process]
   748   C1704322:orientation [Spatial Concept]
   748   C1704972:Orientation [Spatial Concept]
   748   C3539923:Orientation [Intellectual Product]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.289: However, several exceptions to this rule are known, mainly of proteins of which the amino-terminal domain contains more then 17charged amino acid residues (48). 

Phrase: "However,"

Phrase: "several exceptions to this rule"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1554961:exception [Idea or Concept]
   726   C1705847:Exception [Conceptual Entity]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "mainly of proteins of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the amino-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "more then 17charged amino acid residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   766   C1709915:Residue [Conceptual Entity]
   766   C1882936:RESIDUE [Phenomenon or Process]
   716 E C1609982:Residual [Qualitative Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.290: In PS1, this domain contains 29charged residues, which would explain its cytoplasmic orientation. 

Phrase: "In PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "this domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "29charged residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "which"

Phrase: "would"

Phrase: "explain"

Phrase: "its cytoplasmic orientation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0029266:Orientation [Mental Process]
   861   C1704322:orientation [Spatial Concept]
   861   C1704972:Orientation [Spatial Concept]
   861   C3539923:Orientation [Intellectual Product]
Processing 00000000.tx.291: The second issue, which has been pointed out by others before (9, 13, 17), is whether two putative hydrophobic stretches in the PS amino acid sequence flanking the hydrophilic loop, can additionally span the membrane, which would make the presenilins nine transmembrane domain proteins. 

Phrase: "The second issue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033213:Issue [Finding]
   861   C1706387:Issue [Intellectual Product]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "pointed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "out by others"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   790   C1955473:Others [Finding]

Phrase: "before"

Phrase: "(9,"

Phrase: "13,"

Phrase: "17"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "whether"

Phrase: "two putative hydrophobic stretches in the PS amino acid sequence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0270814:Stretches [Disease or Syndrome]
   706 E C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the hydrophilic loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "can"

Phrase: "additionally"

Phrase: "span"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1711300:Span [Conceptual Entity]
  1000   C2700613:Span [Quantitative Concept]

Phrase: "the membrane,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "which"

Phrase: "would"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the presenilins nine transmembrane domain proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   836   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.292: Our data are compatible with a seven-transmembrane domain model with the amino-terminal domain and the hydrophilic loop located in the cytoplasm (Fig. 10; see also Note Added in Proof). 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "compatible with a seven-transmembrane domain model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332290:compatible [Idea or Concept]
   748   C1524057:Compatible [Qualitative Concept]

Phrase: "with the amino-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the hydrophilic loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "located in the cytoplasm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010834:Cytoplasm [Cell Component]

Phrase: "(Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "also"

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Added in Proof"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0556981:% proof [Quantitative Concept]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: ")."
Processing 00000000.tx.293: In conclusion, the current study has analyzed the biosynthesis and the subcellular localization of the presenilins and provides a basis for the further study of their cell biology and their possible interactions with integral membrane and cytoplasmic proteins such as APP or Tau, both implicated in the pathogenesis of Alzheimer's disease (4). 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "the current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005572:biosynthesis [Functional Concept]
  1000   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "the subcellular localization of the presenilins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a basis for the further study of their cell biology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1527178:Basis [Functional Concept]
   739   C1874451:Basis [Pharmacologic Substance]

Phrase: "and"

Phrase: "their possible interactions with integral membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "cytoplasmic proteins such as APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   774   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "Tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "both"

Phrase: "implicated in the pathogenesis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.294: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.295: 10. 

Phrase: "10."
Processing 00000000.tx.296: Localization of antibody epitopes and orientation of PS1 in the endoplasmic reticulum membrane. 

Phrase: "Localization of antibody epitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "orientation of PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0029266:Orientation [Mental Process]
   790   C1704322:orientation [Spatial Concept]
   790   C1704972:Orientation [Spatial Concept]
   790   C3539923:Orientation [Intellectual Product]

Phrase: "in the endoplasmic reticulum membrane."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0230770:endoplasmic reticulum membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]
Processing 00000000.tx.297: PS1 is inserted in the endoplasmic reticulum membrane with both its amino-terminal (NH2-) and hydrophilic loop domain at the cytoplasmic side. 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "inserted in the endoplasmic reticulum membrane"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0230770:endoplasmic reticulum membrane [Cell Component]
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0441587:Inserted [Health Care Activity]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   719 E C1743766:Insert [Medical Device]
   719 E C1883719:Insert [Functional Concept]

Phrase: "with both"

Phrase: "its amino-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "(NH2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002508:NH2 [Organic Chemical]
  1000   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "hydrophilic loop domain at the cytoplasmic side."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1511625:Cytoplasmic Domain [Cell Component]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.298: The localization of the peptides used to raise the different antibodies used to study the topology of PS1 are indicated by bars above the sequence (see also "Materials and Methods" and Note Added in Proof). 

Phrase: "The localization of the peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "raise"

Phrase: "the different antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the topology of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002812:Topology [Biomedical Occupation or Discipline]

Phrase: "are"

Phrase: "indicated by bars"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1444656:Indicated [Finding]
   790   C1707156:BARS [Gene or Genome]
   790   C3274014:BARS [Intellectual Product]
   790   C3541345:BARS [Intellectual Product]

Phrase: "above the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "also ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Added in Proof"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0556981:% proof [Quantitative Concept]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: ")."
Processing 00000000.tx.299: [View Larger Version of this Image (13K GIF file)] FOOTNOTES * This investigation was supported by grants from the Fonds voor Geneeskundig Wetenschappelijk Onderzoek (FGWO-NFWO), the Human Frontiers of Science Program (HFSP), the Action Program for Biotechnology of the Flemish Government (VLAB), the Flemish Institute for Biotechnology (VIB), the Katholieke Universiteit Leuven, the Alzheimer's Society of Ontario, and the Medical Research Council of Canada. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(13K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1261322:Investigation [Health Care Activity]
  1000   C1552578:investigation [Idea or Concept]
   928 E C1517586:Investigational [Qualitative Concept]
   928 E C3245491:investigational [Intellectual Product]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Fonds voor Geneeskundig Wetenschappelijk Onderzoek"

Phrase: "(FGWO-NFWO"

Phrase: ")"

Phrase: ","

Phrase: "the Human Frontiers of Science Program (HFSP),"

Phrase: "the Action Program for Biotechnology of the Flemish Government"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0018106:Program, Government [Governmental or Regulatory Activity]
   742   C1709697:Program [Conceptual Entity]
   742   C2728259:Program [Pharmacologic Substance]
   742   C3484370:Program [Functional Concept]

Phrase: "(VLAB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416496:VLAB [Gene or Genome]
  1000   C3273111:VLAB [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the Flemish Institute for Biotechnology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "(VIB"

Phrase: ")"

Phrase: ","

Phrase: "the Katholieke Universiteit Leuven,"

Phrase: "the Alzheimer's Society of Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037455:society [Organization]

Phrase: "and"

Phrase: "the Medical Research Council of Canada."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0079816:Medical Research [Research Activity]
   790   C1556038:Medical Research [Professional or Occupational Group]
   753   C0035168:research [Research Activity]
   753   C0205476:Medical [Functional Concept]
   753   C0242481:Research [Research Activity]
   753   C1551807:Council [Population Group]
Processing 00000000.tx.300: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.301: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.302: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.303: Onderzoeksleider of the National Fund for Scientific Research, Belgium (NFWO). 

Phrase: "Onderzoeksleider of the National Fund"

Phrase: "for Scientific Research,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "(NFWO"

Phrase: ")."
Processing 00000000.tx.304: To whom correspondence should be addressed: Campus Gasthuisberg, O&N 06,3000Leuven, Belgium. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Campus Gasthuisberg,"

Phrase: "O&N 06,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439114:O NOS [Intellectual Product]

Phrase: "3000Leuven,"

Phrase: "Belgium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]
Processing 00000000.tx.305: Fax: 32-16-345871; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "32-16-345871"

Phrase: ";"
Processing 00000000.tx.306: E-mail: bart.destrooper{at}med.kuleuven.ac.be . 1 The abbreviations used are: PS2, presenilin 2; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "bart.destrooper{at}med.kuleuven.ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1412573:AC [Gene or Genome]
   799   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   799   C3539770:AC [Gene or Genome]

Phrase: "be . 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PS2,"

Phrase: "presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.307: PS1, presenilin 1; 

Phrase: "PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.308: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.309: mAb, monoclonal antibody; 

Phrase: "mAb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: ";"
Processing 00000000.tx.310: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.311: TBS, Tris-buffered saline; 

Phrase: "TBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.312: FITC, fluorescein isothiocyanate; 

Phrase: "FITC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "fluorescein isothiocyanate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.313: TRITC, tetramethylrhodamine isothiocyanate; 

Phrase: "TRITC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076308:TRITC [Organic Chemical,Pharmacologic Substance]

Phrase: "tetramethylrhodamine isothiocyanate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0076308:tetramethylrhodamine isothiocyanate [Organic Chemical,Pharmacologic Substance]
   861   C0076306:tetramethylrhodamine [Organic Chemical,Pharmacologic Substance]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.314: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.315: Pipes, 1,4-piperazinediethanesulfonic acid; 

Phrase: "Pipes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0071109:PIPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   966 E C1709545:PIPE [Pharmacologic Substance]
   966 E C2828033:Pipe [Manufactured Object]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-piperazinediethanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.316: NSP, neuroendocrine-specific protein. 

Phrase: "NSP,"

Phrase: "neuroendocrine-specific protein."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0217373:Neuroendocrine-Specific Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1309732:Neuroendocrine-Specific Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335653:NEUROENDOCRINE-SPECIFIC PROTEIN [Gene or Genome]
   827   C0027912:Neuroendocrine [Body System]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]
Processing 00000000.tx.317: 2 P. 

Phrase: "2 P."
Processing 00000000.tx.318: Fraser, unpublished results. 

Phrase: "Fraser,"

Phrase: "unpublished results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.319: 3 B. 

Phrase: "3 B."
Processing 00000000.tx.320: De Strooper and K.

Phrase: "De Strooper"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.321: Craessaerts, unpublished results. 

Phrase: "Craessaerts,"

Phrase: "unpublished results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.322: 4 D. 

Phrase: "4 D."
Processing 00000000.tx.323: Moechars, B.De Strooper, and F.Van Leuven, unpublished results. 

Phrase: "Moechars,"

Phrase: "B.De Strooper,"

Phrase: "and"

Phrase: "F.Van Leuven,"

Phrase: "unpublished results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.324: Acknowledgments We gratefully acknowledge the contribution of expertise or materials of the following scientists: B.

Phrase: "Acknowledgments"

Phrase: "We gratefully"

Phrase: "acknowledge"

Phrase: "the contribution of expertise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "or"

Phrase: "materials of the following scientists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0520510:Materials [Substance]

Phrase: ":"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.325: Greenberg; 

Phrase: "Greenberg"

Phrase: ";"
Processing 00000000.tx.326: A.

Phrase: "A."
Processing 00000000.tx.327: Roebroek, J.

Phrase: "Roebroek,"

Phrase: "J."
Processing 00000000.tx.328: Creemers, and W.Van De Ven; 

Phrase: "Creemers,"

Phrase: "and"

Phrase: "W.Van De Ven"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0011198:DE [Geographic Area]
   812   C0017480:DE [Geographic Area]
   812   C0042469:VEN [Geographic Area]
   812   C0557775:Van [Manufactured Object]
   812   C3541240:DE [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.329: and G.

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.330: Schellenberg (Geriatric Research, Education and Clinical Center, Seattle, WA). 

Phrase: "Schellenberg"

Phrase: "(Geriatric Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "Education"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "and"

Phrase: "Clinical Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2347782:Clinical Center [Organization]
   861   C0205099:Center [Spatial Concept]

Phrase: "Seattle,"

Phrase: "WA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:WA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.331: Note Added in Proof An eight-transmembrane model, with hydrophobic region VIII in the loop domain spanning the endoplasmic reticulum membrane, is also compatible with these data. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Added in Proof"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0556981:% proof [Quantitative Concept]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "An eight-transmembrane model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "with hydrophobic region VIII"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0445599:VIII [Intellectual Product]
   827   C1413661:VIII [Gene or Genome]

Phrase: "in the loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the endoplasmic reticulum membrane,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0230770:endoplasmic reticulum membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "is"

Phrase: "also compatible with these data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:compatible [Idea or Concept]
   760   C1524057:Compatible [Qualitative Concept]
Processing 00000000.tx.332: This would result in a cytoplasmic orientation of the carboxyl-terminal domain of PS1. 

Phrase: "This"

Phrase: "would"

Phrase: "result in a cytoplasmic orientation of the carboxyl-terminal domain of PS1."
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   751   C1511625:Cytoplasmic Domain [Cell Component]
   736   C0010834:Cytoplasmic [Cell Component]
   736   C0029266:Orientation [Mental Process]
   736   C0205088:Terminal [Temporal Concept]
   736   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0521449:Cytoplasmic [Body Location or Region]
   736   C0596260:Carboxyl [Organic Chemical]
   736   C1274040:Result [Functional Concept]
   736   C1418985:PS1 [Gene or Genome]
   736   C1546471:Result [Idea or Concept]
   736   C1704322:orientation [Spatial Concept]
   736   C1704972:Orientation [Spatial Concept]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   736   C1880389:Domain [Functional Concept]
   736   C1883221:Domain [Conceptual Entity]
   736   C2825142:Result [Finding]
   736   C2986918:PS1 [Gene or Genome]
   736   C3539923:Orientation [Intellectual Product]
   736   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.333: REFERENCES Haass, C., and Selkoe, D. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.334: J. 

Phrase: "J."
Processing 00000000.tx.335: (1993) Cell 75, 1039-1042 [Medline] [OrderarticleviaInfotrieve] Selkoe, D. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cell 75,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1039-1042"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.336: J. 

Phrase: "J."
Processing 00000000.tx.337: (1994) Annu. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.338: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.339: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.340: 10, 373-403 [CrossRef] Checler, F. 

Phrase: "10,"

Phrase: "373-403"

Phrase: "[CrossRef"

Phrase: "] Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.341: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.342: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.343: 65, 1431-1444 [Medline] [OrderarticleviaInfotrieve] Kosik, K. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "1431-1444"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.344: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.345: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.346: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.347: 127, 1501-1504 [Medline] [OrderarticleviaInfotrieve] Haass, C. 

Phrase: "127,"

Phrase: "1501-1504"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Haass,"

Phrase: "C."
Processing 00000000.tx.348: (1996) Curr. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.349: Opin. 

Phrase: "Opin."
Processing 00000000.tx.350: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.351: 9, 254-259 [Medline] [OrderarticleviaInfotrieve] Strittmatter, W. 

Phrase: "9,"

Phrase: "254-259"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Strittmatter,"

Phrase: "W."
Processing 00000000.tx.352: J., and Roses, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.353: D. 

Phrase: "D."
Processing 00000000.tx.354: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.355: Natl. 

Phrase: "Natl."
Processing 00000000.tx.356: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.357: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.358: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.359: 92, 4725-4727 [Abstract] Rebeck, G. 

Phrase: "92,"

Phrase: "4725-4727"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.360: W., Reiter, J. 

Phrase: "W., Reiter,"

Phrase: "J."
Processing 00000000.tx.361: S., Strickland, D. 

Phrase: "S."

Phrase: ","

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.362: K., and Hyman, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.363: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.364: (1993) Neuron 11, 575-580 [Medline] [OrderarticleviaInfotrieve] Goate, A., Chartier-Harlin, M. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Neuron 11,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "575-580"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.365: C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Williamson, Rossor, M., Owen, M., and Hardy, J. 

Phrase: "C., Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Giuffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A.,"

Phrase: "Irving,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "James,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mant,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rooke,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Roques,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Williamson,"

Phrase: "Rossor,"

Phrase: "M."

Phrase: ","

Phrase: "Owen,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.366: (1991) Nature 349, 704-706 [CrossRef][Medline] [OrderarticleviaInfotrieve] Rogaev, E. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Nature 349,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "704-706"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rogaev,"

Phrase: "E."
Processing 00000000.tx.367: I., Sherrington, R., Rogaeva, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.368: A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holamn, K., Tsuda, T., Mar, L., Sorbi, S., Nacmias, B., Piacenti, S., Amaducci, L., Chumakov, I., Cohen, D., Lannfelt, L., Fraser, P. 

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Holamn,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Nacmias,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Piacenti,"

Phrase: "S."

Phrase: ","

Phrase: "Amaducci,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Cohen,"

Phrase: "D."

Phrase: ","

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.369: E., Rommens, J. 

Phrase: "E.,"

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.370: M., and St. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.371: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.372: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.373: (1995) Nature 376, 775-778 [CrossRef][Medline] [OrderarticleviaInfotrieve] Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 376,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "775-778"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.374: M., Osima, J., Pettingell, H., Yu, C., Jondro, P. 

Phrase: "M."

Phrase: ","

Phrase: "Osima,"

Phrase: "J.,"

Phrase: "Pettingell,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.375: D., Schmidt, S. 

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.376: D., Wang, K., Crowley, A. 

Phrase: "D."

Phrase: ","

Phrase: "Wang,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Crowley,"

Phrase: "A."
Processing 00000000.tx.377: C., Fu, Y. 

Phrase: "C., Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C1424823:FU [Gene or Genome]

Phrase: "Y."
Processing 00000000.tx.378: H., Guenette, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.379: Y., Galas, D., Nemens, E., Wijsman, E. 

Phrase: "Y.,"

Phrase: "Galas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0082651:gala [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1439334:GALA [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Wijsman,"

Phrase: "E."
Processing 00000000.tx.380: M., Bird, T. 

Phrase: "M."

Phrase: ","

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.381: D., Schellenberg, G. 

Phrase: "D."

Phrase: ","

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.382: D., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.383: E. 

Phrase: "E."
Processing 00000000.tx.384: (1995) Science 269, 973-977 [Medline] [OrderarticleviaInfotrieve] Li, J., Ma, J., and Potter, H. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "973-977"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "Ma,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.385: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.386: Natl. 

Phrase: "Natl."
Processing 00000000.tx.387: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.388: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.389: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.390: 92, 12180-12184 [Abstract] Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E. 

Phrase: "92,"

Phrase: "12180-12184"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.391: A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J. 

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Foncin,"

Phrase: "J."
Processing 00000000.tx.392: F., Bruni, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bruni,"

Phrase: "A."
Processing 00000000.tx.393: C., Montesi, M. 

Phrase: "C., Montesi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.394: P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polnsky, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Rainero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pinessi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pollen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032385:Pollen [Plant]
  1000   C0795585:POLLEN [Organic Chemical,Pharmacologic Substance]
  1000   C1320238:Pollen [Immunologic Factor]

Phrase: "D."

Phrase: ","

Phrase: "Brookes,"

Phrase: "A.,"

Phrase: "Sanseau,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Polnsky,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.395: J., Wasco, W., da Silva, H. 

Phrase: "J.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "da Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.396: A.R., Haines, J. 

Phrase: "A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.397: L., Pericak-Vance, M. 

Phrase: "L., Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.398: A., Tanzi, R. 

Phrase: "A.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.399: E., Roses, A. 

Phrase: "E.,"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.400: D., Fraser, P. 

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.401: E., Rommens, J. 

Phrase: "E.,"

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.402: M., and St. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.403: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.404: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.405: (1995) Nature 375, 754-760 [CrossRef][Medline] [OrderarticleviaInfotrieve] Alzheimer's Disease Collaborative Group (1995) Nat. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 375,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "754-760"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Alzheimer's Disease Collaborative Group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "(1995"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.406: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.407: 11, 219-222 [Medline] [OrderarticleviaInfotrieve] Wasco, W., Pettingell, W. 

Phrase: "11,"

Phrase: "219-222"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wasco,"

Phrase: "W.,"

Phrase: "Pettingell,"

Phrase: "W."
Processing 00000000.tx.408: P., Jondro, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.409: D., Schmidt, S. 

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.410: D., Gurubhagavatula, S., Rodes, L., DiBlasi, T., Romano, T. 

Phrase: "D."

Phrase: ","

Phrase: "Gurubhagavatula,"

Phrase: "S."

Phrase: ","

Phrase: "Rodes,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "DiBlasi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.411: M., Guenette, S. 

Phrase: "M."

Phrase: ","

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.412: Y., Kovacs, D. 

Phrase: "Y.,"

Phrase: "Kovacs,"

Phrase: "D."
Processing 00000000.tx.413: M., Growdon, J. 

Phrase: "M."

Phrase: ","

Phrase: "Growdon,"

Phrase: "J."
Processing 00000000.tx.414: H., and Tanzi, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.415: E. 

Phrase: "E."
Processing 00000000.tx.416: (1995) Nat. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.417: Med. 

Phrase: "Med."
Processing 00000000.tx.418: 1, 848 [Medline] [OrderarticleviaInfotrieve] Van Broeckhoven, C. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "848"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.419: (1995) Nat. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.420: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.421: 11, 230-232 [Medline] [OrderarticleviaInfotrieve] De Strooper, B., Simons, M., Multhaup, G., Van Leuven, F., Beyreuther, K., and Dotti, C. 

Phrase: "11,"

Phrase: "230-232"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Simons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:simons [Intellectual Product]

Phrase: "M."

Phrase: ","

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Dotti,"

Phrase: "C."
Processing 00000000.tx.422: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.423: (1995) EMBO J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.424: 14, 4932-4938 [Abstract] Slunt, H. 

Phrase: "14,"

Phrase: "4932-4938"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.425: H., Thinakaran, G., Lee, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.426: K., and Sisodia, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.427: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.428: (1995) Int. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.429: J.Exp. 

Phrase: "J.Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.430: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.431: Invest. 

Phrase: "Invest."
Processing 00000000.tx.432: 2, 188-190 Pasquale, V., Lacana, E., and D'Adamio, L. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "188-190 Pasquale,"

Phrase: "V.,"

Phrase: "Lacana,"

Phrase: "E.,"

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.433: (1996) Science 271, 521-525 [Abstract] L'Hernault, S. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Science 271,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "521-525"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] L'Hernault,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.434: W., and Arduengo, P. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Arduengo,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.435: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.436: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.437: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.438: 119, 55-68 [Abstract] Leviatan, D., and Greenwald, I. 

Phrase: "119,"

Phrase: "55-68"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450382:55 [Intellectual Product]
   861   C0450387:68 [Intellectual Product]

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Leviatan,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Greenwald,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.439: (1995) Nature 377, 351-354 [CrossRef][Medline] [OrderarticleviaInfotrieve] Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 377,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "351-354"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.440: D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. 

Phrase: "D."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Kukull,"

Phrase: "W.,"

Phrase: "Larson,"

Phrase: "E.,"

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Viitanen,"

Phrase: "M."

Phrase: ","

Phrase: "Peskind,"

Phrase: "E.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schellenberg,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.441: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.442: Med. 

Phrase: "Med."
Processing 00000000.tx.443: 2, 864-870 [Medline] [OrderarticleviaInfotrieve] Creemers, J. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "864-870"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Creemers,"

Phrase: "J."
Processing 00000000.tx.444: W.M., Vey, M., Schfer, W., Ayoubi, T. 

Phrase: "W."

Phrase: "M."

Phrase: ","

Phrase: "Vey,"

Phrase: "M."

Phrase: ","

Phrase: "Schfer,"

Phrase: "W.,"

Phrase: "Ayoubi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.445: A.Y., Roebroek, A. 

Phrase: "A.Y.,"

Phrase: "Roebroek,"

Phrase: "A."
Processing 00000000.tx.446: J.M., Klenk, H.-D., Garten, W., and Van de Ven, W. 

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Klenk,"

Phrase: "H.-D.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Garten,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Van de Ven,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0011198:DE [Geographic Area]
   827   C0017480:DE [Geographic Area]
   827   C0042469:VEN [Geographic Area]
   827   C0557775:Van [Manufactured Object]
   827   C3541240:DE [Idea or Concept]

Phrase: "W."
Processing 00000000.tx.447: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.448: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.449: Biol. 

Phrase: "Biol."
Processing 00000000.tx.450: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.451: 270, 2695-2702 [Abstract/Free FullText] Roebroek, A. 

Phrase: "270,"

Phrase: "2695-2702"

Phrase: "[Abstract/Free FullText"

Phrase: "] Roebroek,"

Phrase: "A."
Processing 00000000.tx.452: J.M., Schalken, A., Leunissen, J. 

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Schalken,"

Phrase: "A.,"

Phrase: "Leunissen,"

Phrase: "J."
Processing 00000000.tx.453: A.M., Onnekink, C., Bloemers, H. 

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Onnekink,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bloemers,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.454: P.J., and Van de Ven, W. 

Phrase: "P.J.,"

Phrase: "and"

Phrase: "Van de Ven,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0011198:DE [Geographic Area]
   827   C0017480:DE [Geographic Area]
   827   C0042469:VEN [Geographic Area]
   827   C0557775:Van [Manufactured Object]
   827   C3541240:DE [Idea or Concept]

Phrase: "W."
Processing 00000000.tx.455: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.456: (1986) EMBO J. 

Phrase: "(1986"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.457: 5, 2197-2202 [Abstract] Van de Velde, H. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "2197-2202"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Van de Velde,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.458: J.K., Roebroek, A. 

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Roebroek,"

Phrase: "A."
Processing 00000000.tx.459: J.M., Senden, N. 

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Senden,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.460: H.M., Ramaekers, F. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Ramaekers,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.461: C.S., and Van De Ven, W. 

Phrase: "C.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Van De Ven,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0011198:DE [Geographic Area]
   827   C0017480:DE [Geographic Area]
   827   C0042469:VEN [Geographic Area]
   827   C0557775:Van [Manufactured Object]
   827   C3541240:DE [Idea or Concept]

Phrase: "W."
Processing 00000000.tx.462: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.463: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.464: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.465: 107, 2403-2416 [Abstract/Free FullText] Roebroek, A. 

Phrase: "107,"

Phrase: "2403-2416"

Phrase: "[Abstract/Free FullText"

Phrase: "] Roebroek,"

Phrase: "A."
Processing 00000000.tx.466: J.M., Van de Velde, H. 

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Van de Velde,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.467: J.K., Van Bokhoven, A., Broers, J. 

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Van Bokhoven,"

Phrase: "A.,"

Phrase: "Broers,"

Phrase: "J."
Processing 00000000.tx.468: L.V., Ramaekers, F. 

Phrase: "L.V., Ramaekers,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.469: C.S., and Van de Ven, W. 

Phrase: "C.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Van de Ven,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0011198:DE [Geographic Area]
   827   C0017480:DE [Geographic Area]
   827   C0042469:VEN [Geographic Area]
   827   C0557775:Van [Manufactured Object]
   827   C3541240:DE [Idea or Concept]

Phrase: "W."
Processing 00000000.tx.470: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.472: Biol. 

Phrase: "Biol."
Processing 00000000.tx.473: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.474: 268, 13439-13477 [Abstract/Free FullText] Evan, G., Lewis, G. 

Phrase: "268,"

Phrase: "13439-13477"

Phrase: "[Abstract/Free FullText"

Phrase: "] Evan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lewis,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.475: K., Ramsay, G., and Bishop, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ramsay,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Bishop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551458:Bishop [Population Group]

Phrase: "J."
Processing 00000000.tx.476: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.477: (1985) Mol. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.478: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.479: Biol. 

Phrase: "Biol."
Processing 00000000.tx.480: 5, 3610-3616 [Medline] [OrderarticleviaInfotrieve] De Strooper, B., Umans, L., Van Leuven, F., and Van Den Berghe, H. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "3610-3616"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Umans,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Van Den Berghe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.481: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.482: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.483: 121, 295-304 [Abstract] Cooper, J. 

Phrase: "121,"

Phrase: "295-304"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.484: A., Sefton, B. 

Phrase: "A.,"

Phrase: "Sefton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.485: M., and Hunter, T. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.486: (1983) Methods Enzymol. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.487: 99, 387-402 [Medline] [OrderarticleviaInfotrieve] Otto, J. 

Phrase: "99,"

Phrase: "387-402"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Otto,"

Phrase: "J."
Processing 00000000.tx.488: C., and Smith, W. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "W."
Processing 00000000.tx.489: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.490: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.491: Biol. 

Phrase: "Biol."
Processing 00000000.tx.492: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.493: 269, 19868-19875 [Abstract/Free FullText] Napier, R. 

Phrase: "269,"

Phrase: "19868-19875"

Phrase: "[Abstract/Free FullText"

Phrase: "] Napier,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.494: M., Venis, M. 

Phrase: "M."

Phrase: ","

Phrase: "Venis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.495: A., Bolton, M. 

Phrase: "A.,"

Phrase: "Bolton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.496: A., Richardson, L. 

Phrase: "A.,"

Phrase: "Richardson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443048:Richardson [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.497: I., and Butcher, G. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Butcher,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335755:BUTCHER [Professional or Occupational Group]
  1000   C1706208:Butcher [Activity]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.498: W. 

Phrase: "W."
Processing 00000000.tx.499: (1988) Planta 176, 519-526 Munro, S., and Pelham, H. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Planta 176,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0230463:Planta [Body Location or Region]
   789 E C0442036:Plantar [Body Location or Region]

Phrase: "519-526 Munro,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Pelham,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.500: R.B. 

Phrase: "R.B."
Processing 00000000.tx.501: (1987) Cell 48, 899-907 [Medline] [OrderarticleviaInfotrieve] Jorgensen, A., Arnold, W., Pepper, D., Kahl, S., Mandel, F., and Campbell, K. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Cell 48,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "899-907"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jorgensen,"

Phrase: "A.,"

Phrase: "Arnold,"

Phrase: "W.,"

Phrase: "Pepper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453397:Pepper [Plant]
  1000   C1123063:Pepper [Food]

Phrase: "D."

Phrase: ","

Phrase: "Kahl,"

Phrase: "S."

Phrase: ","

Phrase: "Mandel,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.502: (1988) Cell Motil. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Cell Motil."
Processing 00000000.tx.503: Cytoskel. 

Phrase: "Cytoskel."
Processing 00000000.tx.504: 9, 164-174 [Medline] [OrderarticleviaInfotrieve] Slunt, H. 

Phrase: "9,"

Phrase: "164-174"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.505: H., Thakaran, G., Von Koch, C., Lo, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Thakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Von Koch,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lo,"

Phrase: "A."
Processing 00000000.tx.506: C.Y., Tanzi, R. 

Phrase: "C.Y.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.507: E., and Sisodia, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.508: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.509: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.510: Biol. 

Phrase: "Biol."
Processing 00000000.tx.511: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.512: 269, 2637-2644 [Abstract/Free FullText] De Strooper, B., Craessaerts, K., Van Leuven, F., and Van Den Berghe, H. 

Phrase: "269,"

Phrase: "2637-2644"

Phrase: "[Abstract/Free FullText"

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Van Den Berghe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.513: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.514: Biol. 

Phrase: "Biol."
Processing 00000000.tx.515: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.516: 270, 30310-30314 [Abstract/Free FullText] Thinakaran, G., Borchelt, D. 

Phrase: "270,"

Phrase: "30310-30314"

Phrase: "[Abstract/Free FullText"

Phrase: "] Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.517: R., Lee, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.518: K., Slunt, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.519: H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., Hardy, J., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Spitzer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.520: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.521: E., Jenkins, N. 

Phrase: "E.,"

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.522: A., Copeland, N. 

Phrase: "A.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.523: G., Price, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.524: L., and Sisodia, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.525: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.526: (1996) Neuron 17, 181-190 [Medline] [OrderarticleviaInfotrieve] Mercken, M., Takahashi, H., Honda, T., Sato, K., Muryama, M., Nakazato, Y., Noguchi, K., Imahori, K., and Takashima, A. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "181-190"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sato,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Muryama,"

Phrase: "M."

Phrase: ","

Phrase: "Nakazato,"

Phrase: "Y.,"

Phrase: "Noguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Imahori,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.527: (1996) FEBS Lett. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.528: 389, 297-303 [CrossRef][Medline] [OrderarticleviaInfotrieve] Elder, G. 

Phrase: "389,"

Phrase: "297-303"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Elder,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331055:Elder [Plant]
  1000   C0994408:Elder [Organic Chemical,Pharmacologic Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.529: A., Tezapsidis, N., Carter, J., Shioi, J., Bouras, C., Li, H. 

Phrase: "A.,"

Phrase: "Tezapsidis,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Carter,"

Phrase: "J.,"

Phrase: "Shioi,"

Phrase: "J.,"

Phrase: "Bouras,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.530: C., Johnston, J. 

Phrase: "C., Johnston,"

Phrase: "J."
Processing 00000000.tx.531: M., Efthimiopoulos, S., Friedrich, V. 

Phrase: "M."

Phrase: ","

Phrase: "Efthimiopoulos,"

Phrase: "S."

Phrase: ","

Phrase: "Friedrich,"

Phrase: "V."
Processing 00000000.tx.532: L., and Robakis, N. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.533: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.534: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.535: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.536: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.537: 45, 308-320 [CrossRef][Medline] [OrderarticleviaInfotrieve] Kovacs, D. 

Phrase: "45,"

Phrase: "308-320"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kovacs,"

Phrase: "D."
Processing 00000000.tx.538: M., Fausett, H., Page, K. 

Phrase: "M."

Phrase: ","

Phrase: "Fausett,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Page,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.539: J., Kim, T. 

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.540: W., Moir, R. 

Phrase: "W., Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.541: D., Merriam, D. 

Phrase: "D."

Phrase: ","

Phrase: "Merriam,"

Phrase: "D."
Processing 00000000.tx.542: E., Hollister, R. 

Phrase: "E.,"

Phrase: "Hollister,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.543: D., Hallmark, O. 

Phrase: "D."

Phrase: ","

Phrase: "Hallmark,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.544: G., Mancini, R., Felsenstein, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mancini,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Felsenstein,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.545: M., Hyman, B. 

Phrase: "M."

Phrase: ","

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.546: T., Tanzi, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.547: E., and Wasco, W. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Wasco,"

Phrase: "W."
Processing 00000000.tx.548: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.549: Med. 

Phrase: "Med."
Processing 00000000.tx.550: 2, 1-6 Moussaoui, S., Czech, C., Pradier, L., Blanchard, V., Bonici, B., Gohin, M., Imperato, A., and Revah, F. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "1-6 Moussaoui,"

Phrase: "S."

Phrase: ","

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Blanchard,"

Phrase: "V.,"

Phrase: "Bonici,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gohin,"

Phrase: "M."

Phrase: ","

Phrase: "Imperato,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Revah,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.551: (1996) FEBS Lett. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.552: 383, 219-222 [CrossRef][Medline] [OrderarticleviaInfotrieve] Wisniewski, T., Palha, J. 

Phrase: "383,"

Phrase: "219-222"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Palha,"

Phrase: "J."
Processing 00000000.tx.553: A., Ghiso, J., and Frangione, B. 

Phrase: "A.,"

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.554: (1995) Lancet 346, 1366 [Medline] [OrderarticleviaInfotrieve] Koo, E. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Lancet 346,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "1366"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Koo,"

Phrase: "E."
Processing 00000000.tx.555: H., and Squazzo, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Squazzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.556: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.557: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.558: Biol. 

Phrase: "Biol."
Processing 00000000.tx.559: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.560: 269, 17386-17389 [Abstract/Free FullText] Thinakaran, G., Teplow, D. 

Phrase: "269,"

Phrase: "17386-17389"

Phrase: "[Abstract/Free FullText"

Phrase: "] Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.561: B., Siman, R., Greenberg, B., and Sisodia, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Greenberg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.562: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.563: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.564: Biol. 

Phrase: "Biol."
Processing 00000000.tx.565: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.566: 271, 9390-9397 [Abstract/Free FullText] Haass, C., Lemere, C. 

Phrase: "271,"

Phrase: "9390-9397"

Phrase: "[Abstract/Free FullText"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lemere,"

Phrase: "C."
Processing 00000000.tx.567: A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L., and Selkoe, D. 

Phrase: "A.,"

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.568: (1995) Nat. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.569: Med. 

Phrase: "Med."
Processing 00000000.tx.570: 1, 1291-1296 [Medline] [OrderarticleviaInfotrieve] Haass, C., Koo, E. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "1291-1296"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.571: H., Capell, A., Teplow, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.572: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.573: J. 

Phrase: "J."
Processing 00000000.tx.574: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.575: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.576: 128, 537-547 [Abstract] De Strooper, B., Craessaerts, K., Dewachter, I., Moechars, D., Greenberg, B., Van Leuven, F., and Van Den Berghe, H. 

Phrase: "128,"

Phrase: "537-547"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dewachter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Moechars,"

Phrase: "D."

Phrase: ","

Phrase: "Greenberg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Van Den Berghe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.577: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.578: Biol. 

Phrase: "Biol."
Processing 00000000.tx.579: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.580: 270, 4058-4065 [Abstract/Free FullText] Buxbaum, J. 

Phrase: "270,"

Phrase: "4058-4065"

Phrase: "[Abstract/Free FullText"

Phrase: "] Buxbaum,"

Phrase: "J."
Processing 00000000.tx.581: D., Gandy, S. 

Phrase: "D."

Phrase: ","

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.582: E., Cichetti, P., Ehrlich, M. 

Phrase: "E.,"

Phrase: "Cichetti,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ehrlich,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.583: E., Czernik, A. 

Phrase: "E.,"

Phrase: "Czernik,"

Phrase: "A."
Processing 00000000.tx.584: J., Fracasso, R. 

Phrase: "J.,"

Phrase: "Fracasso,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.585: P., Ramabhadran, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ramabhadran,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.586: V., Unterbeck, A. 

Phrase: "V., Unterbeck,"

Phrase: "A."
Processing 00000000.tx.587: J., and Greenhard, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Greenhard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.588: (1990) Proc. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.589: Natl. 

Phrase: "Natl."
Processing 00000000.tx.590: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.591: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.592: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.593: 87, 6003-6006 [Abstract] Gillespie, S. 

Phrase: "87,"

Phrase: "6003-6006"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gillespie,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.594: L., Golde, T. 

Phrase: "L., Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.595: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.596: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.597: (1992) Biochem. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.598: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.599: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.600: Commun. 

Phrase: "Commun."
Processing 00000000.tx.601: 187, 1285-1290 [Medline] [OrderarticleviaInfotrieve] Hartmann, E., Rapoport, T. 

Phrase: "187,"

Phrase: "1285-1290"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hartmann,"

Phrase: "E.,"

Phrase: "Rapoport,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.602: A., and Lodish, H. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Lodish,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.603: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.604: (1989) Proc. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.605: Natl. 

Phrase: "Natl."
Processing 00000000.tx.606: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.607: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.608: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.609: 86, 5786-579049 [Abstract] Bollen, M., and Stalmans, W. 

Phrase: "86,"

Phrase: "5786-579049"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bollen,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Stalmans,"

Phrase: "W."
Processing 00000000.tx.610: (1992) Crit. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Crit."
Processing 00000000.tx.611: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.612: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.613: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.614: Biol. 

Phrase: "Biol."
Processing 00000000.tx.615: 27, 227-281 [Abstract] Lories, V., Cassiman, J.-J., Van den Berghe, H., and David, G. 

Phrase: "27,"

Phrase: "227-281"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lories,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1000556:Lories [Bird]
   966 E C0326002:Lory [Bird]

Phrase: "V.,"

Phrase: "Cassiman,"

Phrase: "J.-J.,"

Phrase: "Van den Berghe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "David,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.616: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.617: Biol. 

Phrase: "Biol."
Processing 00000000.tx.618: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.619: 264, 7009-7016 [Abstract/Free FullText] 1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "264,"

Phrase: "7009-7016"

Phrase: "[Abstract/Free FullText"

Phrase: "] 1997 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

